
    <!DOCTYPE html>
    <html>
    <head>
        <title>Biotech Catalyst Radar Report</title>
        <script src="https://cdn.plot.ly/plotly-latest.min.js"></script>
        <style>
            body { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; margin: 0; padding: 20px; background: #f5f5f5; }
            .container { max_width: 1200px; margin: 0 auto; background: white; padding: 20px; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); }
            h1 { color: #333; }
            .metadata { color: #666; font-size: 0.9em; margin-bottom: 20px; }
            .chart-container { margin-bottom: 40px; border: 1px solid #eee; padding: 10px; border-radius: 4px; }
            table { width: 100%; border-collapse: collapse; margin-top: 20px; }
            th, td { padding: 12px; text-align: left; border-bottom: 1px solid #ddd; }
            th { background-color: #f8f9fa; }
        </style>
    </head>
    <body>
        <div class="container">
            <h1>Biotech Catalyst Radar Report</h1>
            <div class="metadata">Generated on: 2025-12-12 20:56:16</div>
            
            <div class="chart-container">
                <div>                        <script type="text/javascript">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>
        <script charset="utf-8" src="https://cdn.plot.ly/plotly-3.3.0.min.js" integrity="sha256-bO3dS6yCpk9aK4gUpNELtCiDeSYvGYnK7jFI58NQnHI=" crossorigin="anonymous"></script>                <div id="00dc7fd9-cc44-46af-a802-529923b6160d" class="plotly-graph-div" style="height:13960px; width:100%;"></div>            <script type="text/javascript">                window.PLOTLYENV=window.PLOTLYENV || {};                                if (document.getElementById("00dc7fd9-cc44-46af-a802-529923b6160d")) {                    Plotly.newPlot(                        "00dc7fd9-cc44-46af-a802-529923b6160d",                        [{"customdata":[["Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer","Advanced Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma",null],["Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery","Pancreatic Adenocarcinoma",null],["UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study","Type 2 Diabetes Mellitus (T2DM)",null],["ASA in Prevention of Ovarian Cancer (STICs and STONEs)","Ovarian Cancer Prevention",null],["Dendritic Cell Vaccines Against Her2\u002fHer3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer","Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Triple-Negative Breast Carcinoma",null],["Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML","Acute Myeloid Leukemia",null],["Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer","Anal Cancer",null],["Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer","Locally Advanced Adrenal Cortex Carcinoma, Adrenal Cortical Carcinoma, Stage III Adrenal Cortex Carcinoma",null],["Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant","Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm",null],["A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer","Breast Cancer",null],["CD19 & CD20 Bispecific CAR T Cells for Relapsed \u002f Refractory B Cell Hematological Tumors","B-Cell Lymphoblastic Leukemia\u002fLymphoma",null],["Serplulimab Combined with CAPEOX + Celecoxib As Neoadjuvant Treatment for Locally Advanced Rectal Cancer","PMMR, MSS, MSI-L",null],["Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients","Parkinson Disease, Anxiety",null],["A Study of RAY1225 in Participants With Type 2 Diabetes","T2DM (Type 2 Diabetes Mellitus)",null],["Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer","Colorectal Cancer",null],["Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders","AML, ALL, MDS",null],["A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease","Crohn Disease, Colitis, Ulcerative",null],["A Phase 1\u002f2 Study of IDP-121 in Patients With Relapsed\u002fRefractory Hematologic Malignancies","Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double Hit Lymphoma",null],["A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma","Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma",null],["Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab","Solid Tumor, Metastases to Soft Tissue",null],["Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)","Intracerebral Hemorrhage",null],["Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia","B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt-Like Lymphoma With 11q Aberration",null],["Study of Trilaciclib and Lurbinectidin","Lung Cancer, Small-cell Lung Cancer",null],["Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigmentation","Post Burn Facial Hyperpigmentation",null],["Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I\u002fII\uff0cMulti-center, Clinical Study.","Neuroblastoma",null],["A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab","Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma",null],["Feasibility of Semaglutide in Advanced Lung Disease","Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease",null],["The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial","Tinnitus",null],["A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2\u002fNeu Positive (HER2+) Breast Cancer (BC)","Breast Cancer, HER2-positive",null],["Spinal Cord Neuromodulation for Spinal Cord Injury","Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia",null],["Rapid Improvement of Depression of Fluoxetine Combined With ATP","Depression",null],["Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis","Pneumonitis",null],["Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer \uff08CASTLE-08\uff09","Advanced Biliary Tract Cancer",null],["Terazosin Effect on Cardiac Changes in Early Parkinson's Disease","REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease",null],["Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab","Pulmonary Fibrosis",null],["Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma","Kidney Cancer, Renal Cell Carcinoma, Renal Clear Cell Carcinoma",null],["Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel\u002fCarboplatin in Fertility Preserving Surgery","Neoadjuvant Immunotherapy, Cervical Cancer, Fertility-sparing Surgery",null],["Ertugliflozin in Chronic Heart Failure","Heart Failure",null],["A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)","Relapsed or Refractory Acute Myeloid Leukemia (AML)",null],["Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)","Solid Tumor, Adult",null],["Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies","Hematologic Malignancies",null],["Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)","Hepatocellular Carcinoma",null],["A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer","Prostate Cancer",null],["Phase II Clinical Trial of Interleukin-2 in AD","Alzheimer Disease",null],["A Study of Tucatinib and Trastuzumab in People With Rectal Cancer","Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma",null],["Pembrolizumab in Hepatocellular Carcinoma","HCC",null],["Serplulimab Plus Chemotherapy for Early-stage HR+\u002fHER2- Breast Cancer","Breast Cancer",null],["Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis","Atopic Dermatitis",null],["A Study of MIL62 Combined With Orelabrutinib for the Treatment of R\u002fR CD20+B Cell Lymphoma","B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory",null],["A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors","Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma",null],["RFA Plus Carrizumab vs Carrizumab Alone for HCC","Tumor Immunity, Immunosuppression, Radiofrequency Ablation",null],["Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)","Primary Immune Thrombocytopenia",null],["Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)","Advanced Biliary Tract Cancer",null],["Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)","Advanced Intrahepatic Cholangiocarcinoma",null],["NT-101 Topical Ophthalmic Solution in Patients With Wet AMD","Wet Age Related Macular Degeneration, Wet AMD",null],["Cisplatin+Pembrolizumab+RT in Vulvar Cancer","Vulvar Cancer, Vulvar Squamous Cell Carcinoma",null],["A Study to Evaluate in Patients With Parkinsonian Type Disorders","Idiopathic Parkinson Disease",null],["Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes","Asthma, Obesity",null],["VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma","Myeloma, Newly Diagnosed, High Risk",null],["Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients","End Stage Renal Disease on Dialysis, Hemodialysis, Peritoneal Dialysis",null],["Adriamycin and Ifosfamide Combined With Sintilimab","Soft Tissue Sarcoma",null],["Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)","Cutaneous Breast Cancer",null],["Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma","Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E\u002fK Mutated",null],["Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia","Erythroplakia, Oral Leukoplakia",null],["Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT","PCNSL",null],["\"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS\u002fpMMR Colorectal Cancer\"","MCRC",null],["Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel","Healthy Adults",null],["Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation","Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy",null],["Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery","Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8",null],["A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG","Gastric\u002fGastroesophageal Junction Adenocarcinoma",null],["Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma","Mesenchymal Chondrosarcoma",null],["Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously","Erectile Dysfunction",null],["Frontline Oral Arsenic Trioxide for APL","Acute Promyelocytic Leukemia",null],["Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness","Asthma, Wheezing",null],["Fedratinib in Combination with Nivolumab","Primary Myelofibrosis, Secondary Myelofibrosis",null],["Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)","Assisted Reproduction",null],["Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer","Non-small Cell Lung Cancer",null],["Proton Beam Therapy for Chordoma Patients","Chordoma",null],["Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC","EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma",null],["IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus","Pemphigus",null],["Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers","Metastatic Malignant Female Reproductive System Neoplasm",null],["Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma","Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma",null],["Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable\u002fMetastatic Colorectal Cancer","Unresectable\u002fMetastatic Colorectal Cancer",null],["Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)","DLBCL",null],["4FMFES-PET Imaging of ER+ Advanced Breast Cancers","ER+ Breast Cancer",null],["Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer","Non-small Cell Lung Cancer",null],["Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia","Covid-19, Sars-CoV2, Pneumonia",null],["Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes","Advanced Malignant Neoplasm, ATM Gene Mutation, BRCA1 Gene Mutation",null],["Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD","Chronic Kidney Diseases, Metabolic Acidosis, Fatigue",null],["MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia","Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease",null],["Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment","Malignant Fungating Wound",null],["A Phase Ib\u002fII Study of SHR-A1811 Injection in Breast Cancer","Breast Cancer",null],["Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)","PTSD",null],["A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma","Melanoma",null],["A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors","Solid Tumor",null],["A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs","Unresectable Gallbladder Cancer",null],["Phase II Trial of Sacituzumab Govitecan in Recurrent and\u002for Metastatic Secretory Gland Cancers","Gland, Salivary Gland Cancers",null],["Phase 2b Controlled Study of Dosing Techniques - Part B","Dry Eye",null],["Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction","Breast Cancer, Heart Failure",null],["Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy","Alzheimer Disease",null],["Vorinostat in Treating Patients With Metastatic Melanoma of the Eye","Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7",null],["A Study of EXG102-031 in Participants With wAMD","Neovascular Age-related Macular Degeneration",null],["Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma","Classical Hodgkin Lymphoma",null],["Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant","Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia",null],["A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon\u00ae, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation\u002fFlutter After Terminating Its Persistent Form","Atrial Fibrillation, Atrial Flutter",null],["A Study of NTRX-07 in Participants With Alzheimer's Disease","Alzheimer Disease, Mild Cognitive Impairment",null],["RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.","ALL, Adult, Philadelphia-Negative ALL",null],["RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)","Long COVID, Long COVID-19, Hypersomnia",null],["FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer","Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic",null],["Amantadine Therapy for Cognitive Impairment in Long COVID","Long COVID, Post-COVID19 Condition, Post-Acute COVID19 Syndrome",null],["Doxycycline to Protect Heart Muscle After Heart Attacks","ST Segment Elevation Myocardial Infarction, Heart Failure",null],["Efficacy and Safety of AC102 Compared to Steroids in Adults with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)","Hearing Loss, Sensorineural",null],["Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy","Pneumonia, Critically Ill",null],["Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer","Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation",null],["Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas","Glioblastoma, Recurrent, Lower Grade Glioma, Recurrent",null],["Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer","NSCLC, Neoadjuvant Therapy",null],["A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules","Progression",null],["Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer","Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma",null],["CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory\u002fRelapsed Aggressive Non-Hodgkin's Lymphoma (NHL).","Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma",null],["Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.","Ovarian Neoplasms, Ovarian Diseases",null],["Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer","Metastatic Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma, RAS Mutation",null],["Everolimus Aging Study","Aging, Insulin Resistance",null],["A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma","Metastatic Urothelial Carcinoma",null],["Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT","Ocular Graft-versus-host Disease",null],["Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension","Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease",null],["A Phase I Study of Mozobil in the Treatment of Patients With WHIMS","Leukopenia, Neutropenia, Infections",null],["Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial","Cavernous Malformations, Intracerebral Hemorrhage, Brainstem Stroke",null],["A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)","Atrial Fibrillation",null],["Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)","Esophagus Cancer",null],["Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer","Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8",null],["Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck","Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx",null],["Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV","Gram Negative Pneumonia, Gram-Negative Bacterial Infections, Bacteremia Caused by Gram-Negative Bacteria",null],["Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)","Acute Myeloid Leukemia",null],["A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders","Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL",null],["Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1\u002f2\u002f3 (Trk A\u002fB\u002fC), ROS1, or ALK Gene Rearrangements (Fusions)","Breast Cancer, Cholangiocarcinoma, Colorectal Cancer",null],["SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies","Anemia",null],["Phase 2b Controlled Study","Dry Eye Disease",null],["TB006 for Autism Spectrum Disorder","Autism Spectrum Disorder",null],["A Phase Ib\u002fII Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC","Non-Small Cell Lung Cancer With EGFR Mutation",null],["HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged \u22652 Years With Congenital Hyperinsulinism (CHI)","Congenital Hyperinsulinism",null],["IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer","Platinum-resistant Ovarian Cancer",null],["Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study","Advanced Hepatocellular Carcinoma",null],["Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma","Esophageal Cancer, Nimotuzumab, Chemoradiotherapy",null],["Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients","Stroke, Stroke, Ischemic, Stroke; Sequelae",null],["A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer","Extensive-stage Small Cell Lung Cancer",null],["Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC","Hepatocellular Carcinoma Non-resectable, HCC",null],["HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM","Glioblastoma, Anaplastic Astrocytoma",null],["Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM","Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes",null],["Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss","Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma",null],["Trimodality Therapy With\u002fOut Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer","Bladder Cancer",null],["Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas","T-Cell Lymphoma",null],["Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma","Primary Central Nervous System Lymphoma",null],["A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease","Stable Coronary Artery Disease CAD",null],["Low Dose IL-2 for the Treatment of Crohn's Disease","Crohn Disease",null],["PSMA\u002fCD70 Bi-specific CAR-T Cell Therapy","Cancer Disease",null],["Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans","Post Traumatic Stress Disorder, Opioid-use Disorder",null],["Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction","Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Persistent Disease, Refractory Acute Myeloid Leukemia",null],["Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients","Breast Cancer Female",null],["Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease","Sickle Cell Disease, Diffuse Myocardial Fibrosis",null],["Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma","Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma",null],["Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma","Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma",null],["A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma","Lymphoma",null],["A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody","Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer",null],["A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors","PD-L1-selected Solid Tumors",null],["LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer","Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma",null],["Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer","Breast Neoplasm Female, Metastatic Breast Cancer",null],["Dapagliflozin in Allo-HCT for aGVHD","Graft-versus-host Disease (GVHD)",null],["PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients","Acute Lung Injury, Prevention",null],["Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed","Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes",null],["Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)","Renal Cell Carcinoma (RCC)",null],["Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed\u002fRefractory Hodgkin Lymphoma","Hodgkin Lymphoma",null],["Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4\u002f6 Inhibitor","Advanced Breast Cancer",null],["Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer","Pancreatic Neoplasms",null],["Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study","Tuberous Sclerosis Complex, Epilepsy",null],["Caplyta in Borderline Personality Disorder","Borderline Personality Disorder",null],["Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma","Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma",null],["Effects of Mirtazapine on Appetite in Advanced Cancer Patients","Advanced Cancer, Anorexia, Weight Loss",null],["Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy","Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm",null],["CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies","T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia",null],["GD2\u002fCD70 Bi-specific CAR-T Cell Therapy","Cancer Disease",null],["Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease","Parkinson Disease",null],["Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer","Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer",null],["PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors","Locally Advanced or Metastatic Solid Tumors",null],["Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma (NPC)",null],["Nanobody-Based CD19\u002fCD22 Tandem Dual CAR-T Therapy for R\u002fR B-ALL","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma",null],["FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma","Head and Neck Squamous Cell Carcinoma",null],["5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial","Intra-abdominal Cancer",null],["Comparing Chemotherapy With\u002fWithout Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma",null],["A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation","Metastatic Castration Resistant Prostate Cancer",null],["Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN","Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm",null],["Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment","Non Small Cell Lung Cancer, Perioperative Complication",null],["Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks","Postoperative Pain, Nausea and Vomiting, Postoperative, Dizziness",null],["Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma",null],["Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder","Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder",null],["Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer","Prostate Cancer",null],["An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC","Mpox (Monkeypox)",null],["A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol","Alcohol Use Disorder",null],["Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1\u002fPD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma","Esophageal Malignant Neoplasm Primary",null],["A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia","Immune Thrombocytopenia, Treatment",null],["Effect Camostat for Kidney Protection in Chronic Kidney Disease","Chronic Kidney Disease(CKD)",null],["Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers","Cigarette Smoking-Related Carcinoma",null],["A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC","Esophageal Squamous Cell Carcinoma",null],["A Clinical Study of T3011 in Combination With PD-1\u002fPD-L1 Inhibitors in Subjects With Advanced Solid Tumors","Advanced Solid Tumors",null],["GD2\u002fCD56 Bi-specific CAR-T Cell Therapy","Malignant Disease",null],["Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies","Solid Organ Malignancies",null],["Minocycline for Chronic Autoimmune Uveitis","Minocycline, Uveitis, Retinal Degeneration",null],["Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment","Nasopharyngeal Cancer",null],["Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model","Acute Graft-versus-Host Disease",null],["Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder","Urothelial Carcinoma, Bladder Cancer",null],["a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors","Solid Tumor",null],["Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis","Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis",null],["Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2","Alcohol Use Disorder, Hiv, Tobacco Use Disorder",null],["Ramucirumab + Pembrolizumab in Patients With Recurrent\u002fMetastatic Head and Neck Squamous Cell Carcinoma","Head and Neck Squamous Cell Carcinoma",null],["Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors","Advanced Solid Tumor",null],["Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients","Esophageal Cancer, Nimotuzumab, Chemoradiotherapy",null],["Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy","Ischemic Heart Disease",null],["Alpha\u002fBeta TCD HCT in Patients With Inherited BMF Disorders","Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes",null],["A Study to Evaluate CM336 in Adults with Autoimmune Bullous Disease","Autoimmune Bullous Disease",null],["(Neo)Adjuvant BRAF\u002fMEK Inhibition in pN1c Melanoma","Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma",null],["Vaginal Baclofen Suppositories in Chronic Pelvic Pain","Chronic Pelvic Pain Syndrome",null],["Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT","Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety",null],["Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)","Multiple Sclerosis",null],["Intrathecal Combination of Programmed Death-1 (PD-1)\u002fCytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis","Leptomeningeal Metastasis",null],["Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients","Stroke Rehabilitation, Gait Disorders, Neurologic, tDCS",null],["Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation","Inflammatory Disease, Aging Problems, Obese",null],["TheraT\u00ae Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers","Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma",null],["ENB003 Plus Pembrolizumab Phase 1b\u002f2a in Solid Tumors","Cancer, Melanoma, Ovary Cancer",null],["Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer","Gastric Cancer",null],["Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and\u002for Refractory Multiple Myeloma","Multiple Myeloma",null],["Cardamom and Topical Roseomonas in Atopic Dermatitis","Atopic Dermatitis, Eczema",null],["Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma","Esophagogastric Junction Adenocarcinoma",null],["5HTP Regulation Of Asthma In Children","Mild or Moderate Asthma With Allergic Sensitization",null],["Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma","Grade 2 Meningioma, Grade 3 Meningioma, Recurrent Meningioma",null],["Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia","Fibrous Dysplasia",null],["A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines","Malaria, Malaria,Falciparum, Parasitic Disease",null],["A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia","Chronic Lymphocytic Leukemia, COVID-19 Infection",null],["The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients","Anterior Cruciate Ligament Reconstruction",null],["Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis","Metastatic Malignant Neoplasm in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7",null],["Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma","Classical Hodgkin Lymphoma",null],["Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients","Sepsis",null],["CAR- PRISM (PRecision Intervention Smoldering Myeloma)","Multiple Myeloma, Smoldering Multiple Myeloma",null],["Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia","Acute Myeloid Leukemia, Myelodysplastic Syndrome",null],["A Phase I\u002fII Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)","Influenza A",null],["Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer","Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer",null],["A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery","Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8",null],["Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)","Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, Advanced Intrahepatic Cholangiocarcinoma",null],["A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors","Advanced or Metastatic Solid Tumors",null],["The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures","Disease or Disorder",null],["Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)","Postural Orthostatic Tachycardia Syndrome (POTS)",null],["Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma","Asthma",null],["Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury","Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System",null],["Study of ODX (OsteoDex) in Multiple Myeloma","Multiple Myeloma",null],["Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.","Hidradenitis Suppurativa",null],["Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma","Diffuse Large B-Cell Lymphoma",null],["Trilaciclib Prevents Myelosuppression With Chemoradiotherapy","Myelosuppression",null],["Treatment of Moderate to Severe Refractory Crohn's Disease","Crohns Disease",null],["R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse","Diffuse Large B-cell Lymphoma",null],["Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis","Primary Biliary Cholangitis",null],["Venetoclax After TKI to Target Persisting Stem Cells in CML","Chronic Myeloid Leukemia",null],["A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity","Hypothalamic Obesity",null],["Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes","Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk",null],["BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC","Triple-Negative Breast Cancer (TNBC), Brain Metastases",null],["An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia","Immune Thrombocytopenia (ITP), Treatment",null],["A Phase 1\u002f2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer","Non Small Cell Lung Cancer, EGFR Exon 20 Mutation",null],["Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed\u002fRefractory Acute Myeloid Leukemia","Relapsed\u002fRefractory Acute Myeloid Leukemia",null],["Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia","Aplastic Anemia, TPO Receptor Agonists",null],["Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic \" Patient Reported Outcome \") on Breast-related Quality of Life","Breast Cancer",null],["Atezolizumab + Cabozantinib in Patients w\u002f Metastatic, Refractory Pancreatic Cancer","Pancreatic Cancer, Metastatic Pancreatic Cancer",null],["A Study in Subjects With Neurogenic Orthostatic Hypotension","Neurogenic Orthostatic Hypotension",null],["SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)","CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Lymphomatoid Papulosis",null],["Acalabrutinib in CNSL","Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma, Recurrent Central Nervous System Lymphoma",null],["Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia","Sickle Cell Anemia, Beta Thalassemia",null],["Further MT for Antibiotic-Resistant Bacterial Colonization in Inpatients","Multi-drug Resistant Organism",null],["The Effect of Sulfasalazine on CRH Levels in Pregnant Women","Preterm Birth",null],["Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer","EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation",null],["Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC","Spinal Disease",null],["Milk Thistle Clinical Trial in Pediatric NAFLD","Non-Alcoholic Fatty Liver Disease (NAFLD)",null],["Intravenous Estrogen in Kidney Transplant Study","Ischemia Reperfusion Injury",null],["CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children","Pharmacokinetics of Celecoxib in Children",null],["Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas","Salivary Gland Cancer, HER2 Gene Mutation",null],["Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment","Colorectal Cancer",null],["A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors","Advanced Solid Tumor",null],["A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis","Immune-related Colitis, Colitis",null],["A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia","Leukemia",null],["Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression","Bipolar Disorder, Bipolar Depression, Bipolar I Disorder",null],["Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer","Rectal Cancer",null],["Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery","Malignant Neoplasms of Female Genital Organs, Ovarian Cancer, Fallopian Tube Cancer",null],["The Impact of a Virtual Magic Trick Training Program","Autism, Pervasive Developmental Disorder",null],["Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma","Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and\u002for BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements",null],["A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme","Glioblastoma Multiforme, Adult",null],["Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers","Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer",null],["Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL","Diffuse Large B Cell Lymphoma",null],["Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa","HIV I Infection, Tuberculosis",null],["Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)","Sarcoma, Radiosurgery",null],["Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD","Autism Spectrum Disorder (ASD)",null],["A Study of Immune Suppression Treatment for People With Sickle Cell Disease or \u03b2-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","Sickle Cell Disease, Thalassemia, Beta, Thalassemia",null],["Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought","Healthy",null],["Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes","Type 1 Diabetes, Diabetes Mellitus, Type 1",null],["Phase II Study of THDBH120 Injection in Overweight or Obese Subjects","Overweight or Obese",null],["A Phase 1\u002f2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)","Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia",null],["A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults","Shingles, Herpes Zoster Infection, Human",null],["Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis","Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation",null],["NP137 Clinical and Biological Activities Assessment in Patients With Advanced\u002fMetastatic Solid Tumors Treated by Standard Anti PD-1\u002fPD-L1 Immunotherapies","Advanced Solid Tumors, Metastatic Solid Tumors",null],["A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure","Chronic Heart Failure",null],["A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies","Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia",null],["Neurocognitive Decline in Patients With Brain Metastases","Brain Metastases",null],["Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma","Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma",null],["Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors","Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma",null],["BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study","Bipolar Disorder, Depressive Episode",null],["The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors","Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL), AML (Acute Myelogenous Leukemia), Myeloma Multiple",null],["A Study of AT-02 in Subjects With Systemic Amyloidosis.","Amyloidosis; Systemic",null],["Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer","Colon Cancer",null],["A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.","Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations",null],["Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage","Herpes Zoster (HZ)",null],["A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)","Neuromyelitis Optica Spectrum Disorders",null],["Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis","Idiopathic Pulmonary Fibrosis (IPF)",null],["Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?","Alcohol Drinking",null],["Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed\u002fRefractory Peripheral T Cell Lymphoma","Relapsed\u002fRefractory Peripheral T Cell Lymphoma",null],["Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation","Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8",null],["A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults","Psoriasis (PsO)",null],["Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w\u002f Metastatic PAC","Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma",null],["Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients","Inflammatory Response After Surgery, Postoperative Recovery",null],["Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy","CMV",null],["Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer","Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy",null],["Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2","Clear Cell Renal Cell Carcinoma, Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Malignant Solid Neoplasm",null],["Lactobacillus Johnsonii in Children and Adolescents With T1D","Type 1 Diabetes (T1D)",null],["Nodular Shrinking in Dupuytren Disease","Dupuytren's Disease",null],["Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib","Multiple Myeloma in Relapse, Refractory Multiple Myeloma",null],["Chemotherapy (DA-EPOCH+\u002f-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia","B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",null],["Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms","Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome",null],["TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)","Breast Cancer",null],["STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer","Malignant Neoplasm of Prostate, Locally Advanced Prostate Cancer",null],["Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI","STEMI, STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction (MI)",null],["A Study of IBI363 in Subjects with Advanced Solid Malignancies","Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer",null],["Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis","MRI-guided Adaptive Radiotherapy, Non-small Cell Lung Cancer, Brain Metastasis",null],["A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS","Advanced Solid Tumors",null],["A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS","Acute Ischemic Stroke AIS",null],["Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee","Subchondral Insufficiency Fracture",null],["Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment","Advanced NSCLC",null],["Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases","Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer",null],["Efficacy and Safety of 500mg of Fulvestrant","Breast Cancer",null],["Study of Intra-articular Allocetra in Knee Osteoarthritis","Osteoarthritis, Knee",null],["First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors","Advanced Solid Tumor, Metastatic Solid Tumor",null],["A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome","Sjogren's Syndrome",null],["Pembrolizumab in Treating Patients With Malignant Mesothelioma","Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma",null],["Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r\u002fr B-NHL","Non-hodgkin Lymphoma,B Cell",null],["Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy","Anaplastic Thyroid Cancer",null],["GEN1047 for Solid Tumors - First in Human (FIH) Trial","Breast Cancer, Breast Neoplasms, Endometrial Cancer, Endometrial Neoplasm, Ovarian Cancer, Ovarian Neoplasms",null],["A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)","Systemic Lupus Erythematosus",null],["Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI","Non Small Cell Lung Cancer",null],["Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.","Muscle Atrophy",null],["A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures","Epilepsy, Generalized, Epilepsy, Absence",null],["ATORvastatin in Pulmonary TUBerculosis","Pulmonary Tuberculosis, Tuberculosis, Koch's Disease",null],["Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy","Sepsis, Severe",null],["Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients","Non-squamous NSCLC",null],["Post-operative Urinary Retention (POUR) Following Thoracic Surgery","Urinary Retention",null],["APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors","Solid Tumors, Advanced Cancer, Renal Cancer",null],["Clinical Trial on Agitation in Alzheimer's Dementia","Alzheimer Disease, Agitation,Psychomotor, Care Giving Burden",null],["Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome","Acute Coronary Syndrome",null],["Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial)","Pain, Neuropathic Pain, Irritability",null],["Phase 2 Study of Dacomitinib in NSCLC","NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV",null],["A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT","Acute Ischemic Stroke",null],["Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant","Allogeneic Stem Cell Transplantation",null],["A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer","Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer",null],["Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation","Hemodialysis",null],["An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations","Brain Arteriovenous Malformations",null],["Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia","Aggressive NK Cell Leukemia",null],["Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease","Chronic Kidney Diseases",null],["Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma","Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer",null],["A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer","Rectal Cancer",null],["A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma","Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma",null],["A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy","Melanoma",null],["rTMS to Improve Cognition in Parkinson's","Parkinson's Disease, Mild Cognitive Impairment",null],["Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)","Rift Valley Fever",null],["CERebrolysin In CADASIL","Cadasil",null],["Antibiotic Prophylaxis for Neurogenic Bladder Botox","Neurogenic Bladder, Post-operative Urinary Tract Infections",null],["Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia","Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma",null],["A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease","Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)",null],["DOR\u002fTDF\u002f3TC Switch With M184V\u002fI in People With Controlled HIV (Drive Off-Road)","Hiv",null],["NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial","Metastatic Breast Cancer",null],["Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer","Prostate Cancer",null],["Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)","Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Metabolic Dysfunction-Associated Steatohepatitis",null],["Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients","Metastatic Renal Cell Carcinoma",null],["CD7 CAR T-Cell Therapy for r\u002fr T-cell Lymphomas","T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)",null],["Targeted Naltrexone to Support Individuals Participating in Dry January","Alcohol Misuse",null],["A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)","Juvenile Idiopathic Arthritis",null],["RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)","Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19",null],["Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies","T-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia",null],["A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy","Minimal Residual Disease, Adjuvant Chemotherapy, Colorectal Cancer",null],["Study of the CDK4\u002f6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6","Cancer",null],["Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia","Schizophrenia",null],["Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)","Overweight, Type 2 Diabetes, Obesity",null],["A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis","Moderate to Severe Ulcerative Colitis",null],["Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells","Unresectable Hepatocellular Carcinoma",null],["A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors","Advanced Solid Tumors",null],["A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer","Metastatic Colorectal Cancer",null],["Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage","Sub-arachnoid Haemorrhage",null],["Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","Norovirus Acute Gastroenteritis",null],["Novel MGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes","Alcohol Use Disorder",null],["A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer","Advanced Metastatic Castration Resistant Prostate Cancer",null],["Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study","Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma",null],["Radical Concurrent Chemoradiotherapy With DDP\u002f5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma","Rectal Squamous Cell Carcinoma",null],["Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B\u002fKEYMAKER-U02)","Melanoma",null],["Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma","Hepatocellular Carcinoma",null],["Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma","Craniopharyngiomas",null],["A Modular Phase 1\u002f2 Study With CT7439 in Participants With Solid Malignancies","Solid Malignancies",null],["A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma","Hematologic Malignancies",null],["A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer","Esophageal Cancer, Dysphagia, Esophageal, Epigallocatechin Gallate",null],["A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity","Obesity or Overweight",null],["Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial","Chronic Rhinosinusitis (CRS)",null],["CD7 CAR-T Bridging to alloHSCT for R\u002fR CD7+Malignant Hematologic Diseases","Hematologic Diseases, Neoplasms",null],["Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)","Multiple Myeloma",null],["A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy","Chemotherapy-induced Peripheral Neuropathy",null],["Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy","Carcinoma, Non-Small-Cell Lung",null],["A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer","Pancreatic Cancer",null],["Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)","Asthma With Allergic Rhinitis",null],["a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia","Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib",null],["Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis\u002fChronic Fatigue Syndrome","Chronic Fatigue Syndrome, Myalgic Encephalomyelitis",null],["Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR\u002fMSS LARC.","Rectal Cancer Patients",null],["Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)","Parkinson Disease",null],["A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","Non-Small Cell Lung Cancer",null],["A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils","Chronic Obstructive Pulmonary Disease (COPD)",null],["Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)","Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair",null],["Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma","Grade I Meningioma, Adult, Grade II Meningioma, Adult, Grade III Meningioma, Adult",null],["Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis","Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8",null],["TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)","Breast Cancer",null],["Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer","Triple-negative Breast Cancer, Cadonilimab",null],["Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy","Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes",null],["An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection","Influenza, Human, Arthralgia",null],["A Phase Ib\u002fII Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC","Malignant Pleural Effusions, NSCLC Stage IV",null],["Dopaminergic Dysfunction in Late-Life Depression","Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant",null],["Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240\u002fPRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)","Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease",null],["A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)","Metabolic Dysfunction-associated Steatohepatitis (MASH)",null],["Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)","Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset",null],["RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients","Bladder Cancer, Muscle-Invasive Bladder Carcinoma",null],["A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma","Newly Diagnosed Diffuse Large B-cell Lymphoma",null],["Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma","Locally Advanced Thymoma",null],["Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy","Lymphoma, Follicular Lymphoma, Lymphoma,Non-Hodgkin",null],["Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma",null],["Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure","Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown",null],["Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer","Breast Cancer Female, Hormone Receptor Positive Tumor",null],["Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome","PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries",null],["Vitiligo Treatment by Targeting TYK2 Mediated Responses","Vitiligo, Generalized",null],["Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.","PNH - Paroxysmal Nocturnal Hemoglobinuria",null],["A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer","Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms",null],["The Communicate Study Partnership","Aboriginal Health, Cultural Safety, Access to Interpreters",null],["Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer","Metastatic Castrate-Resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)",null],["A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer","Metastatic Colorectal Cancer",null],["Beetroot Juice NO Cold Study","Respiratory Tract Infections, Cold Symptoms, Exhaled Nitric Oxide",null],["A Phase \u2160b\u002f\u2161 Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML","Acute Myeloid Leukemia, Adult",null],["Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.","Diabetic Foot Ulcer, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)",null],["Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease","Diabetic Kidney Disease (DKD)",null],["Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder","Autism Spectrum Disorder",null],["Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer","Head and Neck Squamous Cell Carcinoma",null],["A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric\u002fGastroesophageal Junction Adenocarcinoma","Gastric\u002fGastroesophageal Junction Adenocarcinoma",null],["Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI","Posttraumatic Headache, Mild Traumatic Brain Injury",null],["Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98\u002fKEYNOTE-B98)","Small Cell Lung Carcinoma",null],["COAST Therapy in Advanced Solid Tumors and Prostate Cancer","Prostate Cancer Recurrent, Solid Tumor, Adult",null],["Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases","Breast Cancer Stage IV",null],["A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults","Pneumococcal Disease",null],["Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","Chronic Lymphocytic Leukemia\u002fSmall Lymphocytic Lymphoma",null],["Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects","Bronchial Asthma",null],["Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML","Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)",null],["Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors","Cancer, Remission",null],["ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer","Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma",null],["D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)","Major Depressive Disorder",null],["Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age","Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis",null],["A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma","Follicular Lymphoma, Marginal Zone Lymphoma",null],["Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy","Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm",null],["Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed\u002fRefractory Diffuse Large B-cell Lymphoma","Diffuse Large B Cell Lymphoma",null],["Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent\u002fMetastatic Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma by AJCC V8 Stage",null],["A Phase 1b\u002f2a, Study Evaluating the Safety, PK\u002fPD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients","Seneorineural Deafness, Sudden Sensorineural Hearing Loss",null],["R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia","Waldenstr\u00f6m's Macroglobulinemia",null],["The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM","Gastric Cancer, Metastatic",null],["Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia","Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Biphenotypic Leukemia",null],["Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer","Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8",null],["Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)","Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8",null],["A Phase \u2161 Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC","Non-Small Cell Lung Cancer",null],["Effect of Belimumab on Antibody Titers in Primary APS Patients","Antiphospholipid Syndrome (APS)",null],["Fluzoparib Neoadjuvant Therapy for Ovarian Cancer","Ovarian Cancer",null],["OSU6162 as add-on in SSRI\u002fSNRI-resistant Depression","Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder",null],["Migraine Manager (R01)","Migraine, Migraine Disorders",null],["Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia","Dyslipidemias",null],["Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma","Multiple Myeloma, Myeloma Multiple, Kahler Disease",null],["A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)","Myelofibrosis",null],["Reducing Innate Inflammation in New Onset Type 1 Diabetes","Type 1 Diabetes, type1diabetes, Type 1 Diabetes Mellitus",null],["CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease","Systemic Lupus Erythematosus, Systemic Sclerosis, Dermatomyositis",null],["RNS System LGS Feasibility Study","Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable",null],["BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r\u002fr B-ALL","Acute Lymphocytic Leukemia",null],["Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)","Mantle Cell Lymphoma",null],["A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke","Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke",null],["ZN-c3 + Gemcitabine in Pancreatic Cancer","Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma",null],["Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)","Post COVID-19 Condition, Long COVID Syndrome, Persistent COVID-19",null],["TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer","Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma",null],["Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge","Non-Small Cell Lung Cancer",null],["Detoxification of the Liver In PSC (Dolphin)","Primary Sclerosing Cholangitis",null],["Scalp Cooling in MBC","Metastatic Breast Cancer, Chemotherapy-induced Alopecia",null],["All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma","Glioma, IDH Mutation, Astrocytoma",null],["Tocilizumab and Tofacitinib in the Treatment of Vascular Beh\u00e7et's Syndrome","Aneurysm, Behcet Syndrome, Vascular Type",null],["A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old","Lupus Nephritis",null],["Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients","Metastatic Pancreatic Ductal Adenocarcinoma",null],["Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial","Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm",null],["A Phase 1\u002f2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia","Glanzmann Thrombasthenia",null],["Cabozantinib Combined With Ipilimumab\u002fNivolumab and TACE in Patients With Hepatocellular Carcinoma","Hepatocellular Carcinoma, HCC",null],["Pharmacogenomics for Better Treatment of Fungal Infections in Cancer","Fungal Infection, Haematological Malignancy, Blood Cancer",null],["Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (\u00b1 Navitoclax) in Relapsed\u002fRefractory Mantle Cell Lymphoma","Mantle Cell Lymphoma Refractory",null],["A Window-of-Opportunity Trial of Giredestrant +\u002f- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive\u002fHER2-negative Early Breast Cancer","Breast Cancer",null],["Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage","Giant Cell Tumor of Bone",null],["To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer","Non-Small Cell Lung Cancer",null],["A Single-arm, Prospective Phase \u2161 Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC","Metastatic Breast Cancer",null],["A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC","Intrahepatic Cholangiocarcinoma (Icc)",null],["CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome","Acute Myeloid Leukemia With Gene Mutations, Myelodysplastic Syndrome, Myeloproliferative Neoplasm",null],["Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.","Marginal Zone Lymphoma",null],["A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)","Myelodysplastic Syndromes",null],["A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract","Urothelial Carcinoma",null],["In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial","Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8",null],["RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression","Non-Muscle Invasive Bladder Cancer, HER2",null]],"hovertemplate":"phase=Phase 2\u003cbr\u003eEstimated Completion=%{x}\u003cbr\u003eTicker=%{y}\u003cbr\u003etitle=%{customdata[0]}\u003cbr\u003econdition=%{customdata[1]}\u003cbr\u003emarket_cap=%{customdata[2]}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Phase 2","marker":{"color":"#636efa","symbol":"circle"},"mode":"markers","name":"Phase 2","orientation":"v","showlegend":true,"x":["2025-12-12T00:00:00.000000000","2025-12-12T00:00:00.000000000","2025-12-12T00:00:00.000000000","2025-12-15T00:00:00.000000000","2025-12-15T00:00:00.000000000","2025-12-15T00:00:00.000000000","2025-12-15T00:00:00.000000000","2025-12-16T00:00:00.000000000","2025-12-16T00:00:00.000000000","2025-12-17T00:00:00.000000000","2025-12-18T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-22T00:00:00.000000000","2025-12-23T00:00:00.000000000","2025-12-24T00:00:00.000000000","2025-12-25T00:00:00.000000000","2025-12-25T00:00:00.000000000","2025-12-25T00:00:00.000000000","2025-12-26T00:00:00.000000000","2025-12-26T00:00:00.000000000","2025-12-28T00:00:00.000000000","2025-12-28T00:00:00.000000000","2025-12-29T00:00:00.000000000","2025-12-29T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-05T00:00:00.000000000","2026-01-06T00:00:00.000000000","2026-01-09T00:00:00.000000000","2026-01-10T00:00:00.000000000","2026-01-12T00:00:00.000000000","2026-01-14T00:00:00.000000000","2026-01-15T00:00:00.000000000","2026-01-15T00:00:00.000000000","2026-01-15T00:00:00.000000000","2026-01-15T00:00:00.000000000","2026-01-16T00:00:00.000000000","2026-01-20T00:00:00.000000000","2026-01-20T00:00:00.000000000","2026-01-20T00:00:00.000000000","2026-01-21T00:00:00.000000000","2026-01-27T00:00:00.000000000","2026-01-27T00:00:00.000000000","2026-01-28T00:00:00.000000000","2026-01-29T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-02T00:00:00.000000000","2026-02-04T00:00:00.000000000","2026-02-06T00:00:00.000000000","2026-02-09T00:00:00.000000000","2026-02-09T00:00:00.000000000","2026-02-13T00:00:00.000000000","2026-02-13T00:00:00.000000000","2026-02-16T00:00:00.000000000","2026-02-17T00:00:00.000000000","2026-02-20T00:00:00.000000000","2026-02-24T00:00:00.000000000","2026-02-24T00:00:00.000000000","2026-02-25T00:00:00.000000000","2026-02-26T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-03T00:00:00.000000000","2026-03-05T00:00:00.000000000","2026-03-05T00:00:00.000000000","2026-03-10T00:00:00.000000000","2026-03-15T00:00:00.000000000","2026-03-15T00:00:00.000000000","2026-03-15T00:00:00.000000000","2026-03-17T00:00:00.000000000","2026-03-19T00:00:00.000000000","2026-03-20T00:00:00.000000000","2026-03-20T00:00:00.000000000","2026-03-25T00:00:00.000000000","2026-03-26T00:00:00.000000000","2026-03-29T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-02T00:00:00.000000000","2026-04-03T00:00:00.000000000","2026-04-05T00:00:00.000000000","2026-04-08T00:00:00.000000000","2026-04-12T00:00:00.000000000","2026-04-13T00:00:00.000000000","2026-04-14T00:00:00.000000000","2026-04-15T00:00:00.000000000","2026-04-17T00:00:00.000000000","2026-04-19T00:00:00.000000000","2026-04-20T00:00:00.000000000","2026-04-20T00:00:00.000000000","2026-04-20T00:00:00.000000000","2026-04-20T00:00:00.000000000","2026-04-22T00:00:00.000000000","2026-04-22T00:00:00.000000000","2026-04-22T00:00:00.000000000","2026-04-23T00:00:00.000000000","2026-04-24T00:00:00.000000000","2026-04-25T00:00:00.000000000","2026-04-26T00:00:00.000000000","2026-04-26T00:00:00.000000000","2026-04-28T00:00:00.000000000","2026-04-28T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-05T00:00:00.000000000","2026-05-06T00:00:00.000000000","2026-05-11T00:00:00.000000000","2026-05-11T00:00:00.000000000","2026-05-13T00:00:00.000000000","2026-05-15T00:00:00.000000000","2026-05-15T00:00:00.000000000","2026-05-15T00:00:00.000000000","2026-05-15T00:00:00.000000000","2026-05-15T00:00:00.000000000","2026-05-15T00:00:00.000000000","2026-05-16T00:00:00.000000000","2026-05-19T00:00:00.000000000","2026-05-19T00:00:00.000000000","2026-05-20T00:00:00.000000000","2026-05-21T00:00:00.000000000","2026-05-23T00:00:00.000000000","2026-05-23T00:00:00.000000000","2026-05-26T00:00:00.000000000","2026-05-26T00:00:00.000000000","2026-05-26T00:00:00.000000000","2026-05-28T00:00:00.000000000","2026-05-28T00:00:00.000000000","2026-05-29T00:00:00.000000000","2026-05-29T00:00:00.000000000","2026-05-30T00:00:00.000000000","2026-05-30T00:00:00.000000000","2026-05-30T00:00:00.000000000","2026-05-30T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-02T00:00:00.000000000","2026-06-02T00:00:00.000000000","2026-06-06T00:00:00.000000000","2026-06-08T00:00:00.000000000"],"xaxis":"x","y":[[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["SLGN",81],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["NTLA",86],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],["MRTX",84],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["VYGR",88],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],["MRTX",84],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["BMY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["CORT",83],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PTCT",89],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["HRTX",90],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["AZN",100],[null,0],[null,0],[null,0],["CARA",80],[null,0],["REGN",100],["AZN",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PHAT",91],[null,0],[null,0],[null,0],["CARA",83],[null,0],[null,0],[null,0],[null,0],["CARA",89],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["BEAM",82],[null,0],["INCY",100],[null,0],[null,0],[null,0],[null,0],[null,0],["CRVS",90],["REGN",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],["AZN",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["AMGN",100],[null,0],[null,0],[null,0],[null,0],["BMY",100],[null,0],["IMUX",91],["NRIX",85],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["SNY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],["PFE",100],[null,0],["MRNA",100],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["DNLI",100],[null,0],["AZN",100],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["DGXA",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["BMY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["BIIB",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0]],"yaxis":"y","type":"scatter"},{"customdata":[["A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight","Obesity, Diabetes Mellitus, Type 2",null],["Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure","Dexmedetomidine",null],["A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India","Rotavirus Infection of Children",null],["A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough","Cough, Refractory Chronic Cough",null],["Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis","Pancreatic Diseases",null],["Nebulized Tranexamic Acid in Sinus Surgery","Bleeding Nose",null],["B\u002fF\u002fTAF to DTG\u002f3TC Switch Study","HIV-1-infection",null],["Randomized Clinical Trial: Oral Health Package Law and Fluor Varnish Impact on Schoolchildren in Merida, Mexico","Caries, Gum Disease",null],["A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients","Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)",null],["Colchicine and Inflammation in Aortic Stenosis","Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Calcification",null],["Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors","Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm",null],["Small Bites Vs Large Bites Abdominal Midline Incisional Closure","Suture Techniques, Wound Closure Techniques, Laparotomy\u002fStanderds",null],["The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years","Diffuse Large B-Cell Lymphoma",null],["TIzanidine for the Preventive Treatment of Episodic MigrainE \uff08TIME\uff09","Migraine Without Aura, Migraine With Aura",null],["Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer","Colorectal Cancer",null],["A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer","Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus",null],["Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC","Non-small Cell Lung Cancer",null],["Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer","Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8, Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8",null],["Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia","Iron Deficiency Anemia of Pregnancy",null],["Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity","Stroke",null],["Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","Endometrial Cancer, Atypical Endometrial Hyperplasia",null],["Maximal Tumor Eradication for Oligometastatic Prostate Cancer","Oligometastatic Prostate Cancer",null],["A Study of Apabetalone in Subjects With Long -COVID","Post-Acute COVID-19 Syndrome",null],["Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer","Non Small Cell Lung Cancer, Small Cell Lung Cancer",null],["Phase III Study of Toripalimab\uff08JS001\uff09 Combined With Lenvatinib for Advanced HCC","Advanced Hepatocellular Carcinoma (HCC)",null],["A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy","Non-small Cell Lung Cancer (NSCLC)",null],["Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)","T-cell Lymphoblastic Lymphoma",null],["A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer","Carcinoma, Small Cell Lung",null],["High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia","Anemia",null],["Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion","Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion",null],["A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR\u002fMSI Status","Toripalimab, Radiation",null],["IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia","Focal Hand Dystonia",null],["Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care","Depression, Cardiovascular Diseases",null],["The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients","Methanol Poisoning",null],["Rapid Maxillary Expansion with Low Level Laser Therapy","Crossbite, Malocclusion, Cross Bite",null],["Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression","Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative",null],["Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ","Breast Ductal Carcinoma in Situ",null],["An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old","Cervical Cancer, Condylomata Acuminata",null],["A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy","PNH",null],["Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis","Cardiac Amyloidosis",null],["Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)","Ischemic Stroke, Acute",null],["EUS-GBD vs Antibiotics for Patients at High Risk for Cholecystectomy","Acute Cholecystitis",null],["Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V","CKD Stage 5",null],["Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis","Cirrhosis",null],["Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC","Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)",null],["Teen Driving Translation Study (NIH)","Drive, Recidivism, Communication",null],["Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia","Chronic Primary Immune Thrombocytopenia (ITP)",null],["68Ga-DOTA-TATE PET\u002fCT Imaging in NETs","Neuroendocrine Tumors",null],["A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma","Small Bowel Adenocarcinoma",null],["Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT","Limited Stage Small Cell Lung Cancer",null],["CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts","Pancreatic Cyst, EUS-FNA",null],["68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI","Prostate Cancer (Adenocarcinoma)",null],["A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)","Relapsed or Refractory Multiple Myeloma",null],["Azithromycin for Critical Asthma - Pediatrics","Pediatric Asthma, Critical Illness",null],["JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo","Monkeypox Virus Infection",null],["V114 and Acute Otitis Media (V114-032\u002fPNEU-ERA)","Acute Otitis Media (AOM)",null],["Perioperative Intravenous Lidocaine in Liver Surgery","Liver Metastases, Liver Cancer, Postoperative Pain",null],["Oxybutynin for Post-surgical Bladder Pain and Urgency","Overactive Bladder Syndrome, Neuropathic Bladder",null],["Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years","Irritable Bowel Syndrome With Constipation (IBS-C)",null],["Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer","Gastric Cancer Stage II, Gastric Cancer Stage III, Gastric Cancer",null],["Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma","Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma",null],["Sublobar Resection for Adenocarcinoma in Situ\u002fMinimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)","Lung Adenocarcinoma, Frozen Section, Sublobar Resection",null],["Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy","Cardiomyopathies",null],["An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.","Acute Myeloid Leukemia (AML)",null],["Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease","Crohn Disease, Nutrient; Excess, Remission\u002fRegression",null],["Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)","Immunoglobulin A Nephropathy, IgAN",null],["Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204\u002fKEYNOTE-204)","Hodgkin Lymphoma",null],["A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis","Progressive Multiple Sclerosis (PMS)",null],["A Study of HS-20094 in Chinese Adults with Overweight or Obesity","Overweight, Obesity",null],["A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection","Hepatocellular Carcinoma",null],["Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women","Infertility, Female, Anovulatory Infertility, Menopause",null],["Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy","Breast Cancer",null],["Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients","Menopause, Premature, Menopause Related Conditions, Menopausal Syndrome",null],["A Study of Daratumumab","Multiple Myeloma",null],["The Study of Efficacy and Safety of Dimephosphon\u00ae in Acute Ischemic Stroke","Stroke, Acute Stroke, Ischemic Stroke",null],["Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome","Encephalopathy, Hypoxic-Ischemic, Infant, Newborn, Diseases",null],["A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer","Non-Small Cell Lung Cancer",null],["Natural Versus Programmed Frozen Embryo Transfer (NatPro)","Pregnancy Related, Pre-Eclampsia",null],["LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.","Acquired Blepharophimosis",null],["Assessing Tenapanor as a Treatment of CF-related Constipation.","Cystic Fibrosis, Constipation",null],["Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer","Rectal Cancer",null],["A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen\u00ae) in Children Aged 6 to \u003c10 Years Compared to Children Aged 2 to \u003c6 Years","Enterovirus 71 Inactivated Vaccine",null],["Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery","Postoperative Urinary Retention (POUR)",null],["A Multi-center, Randomized, Double-blind, Phase II\u002fIII Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)","Recurrent or Metastatic Nasopharyngeal Carcinoma",null],["Long-term Better Than Short-term ADT With Salvage RT","Prostate Cancer",null],["A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease","Thyroid Eye Disease",null],["A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)","Carcinoma, Renal Cell",null],["Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission","Giant Cell Arteritis",null],["The Role of Peripheral Afferents in Modulating Post-stroke Central Pain","Stroke",null],["Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer","Rectal Cancer",null],["Lignin in Treatment of Helicobacter Pylori Infection","HELICOBACTER PYLORI INFECTIONS",null],["Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer","Breast Cancer, Refractory Breast Carcinoma",null],["A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin","Type 2 Diabetes",null],["Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","Branch Atheromatous Disease",null],["Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD","Cardiovascular Disease and Lipoprotein(a)",null],["Phase 3 Study of ALXN1850 in Treatment-Na\u00efve Pediatric Participants With HPP","Hypophosphatasia",null],["Effect of Probiotics \"Psychobiotics\" on Depression and Metabolic Syndrome in Saudi Arabia","Depression Anxiety Disorder",null],["Regorafenib-pembrolizumab vs. TACE\u002fTARE in Intermediate Stage HCC Beyond Up-to-7","Carcinoma, Hepatocellular",null],["Study About Group and Phone Follow-Up After a Crisis","Suicide, Crisis; Emotional",null],["Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer","Non-Small Cell Lung Cancer",null],["MANDARIN (S6371)","Inoperable Hepatocellular Carcinoma",null],["To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC","Extensive Stage Small Cell Lung Cancer",null],["Weight Management Plus LNG-IUS\u002fMegestrol Acetate in Endometrial Atypical Hyperplasia","Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity",null],["A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity","Neurogenic Detrusor Overactivity",null],["Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation","Tobacco Dependence",null],["Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache","Posttraumatic Headache",null],["Clinical and Radiographic Evaluation of Three Biomimetic Materials in Pulp Therapy of Immature Young Permanent Teeth \"A Randomized Controlled Clinical Trial\"","Pulpotomy of Young Permanent Molars",null],["Effect of GH on the Blastocyst Euploid Rate in AMA Patients","Preimplantation Genetic Testing, Growth Hormone, Age, Parental",null],["Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma","Gastric or Esophagogastric Junction Adenocarcinoma",null],["A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia","Warm Autoimmune Hemolytic Anemia (wAIHA)",null],["Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy","Modified Radical Mastectomy, Breast Cancer",null],["A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)","Carcinoma, Squamous Cell, Skin Neoplasms",null],["Aggressive Smoking Cessation Trial (ASAP)","Acute Coronary Syndrome, Cardiovascular Diseases",null],["Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment","Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm",null],["A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).","Primary Immune Thrombocytopenia",null],["A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer","Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)",null],["A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy","Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC V8",null],["An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM","Obstructive Hypertrophic Cardiomyopathy",null],["Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC","Triple Negative Breast Neoplasms",null],["Combination of Hypothermia and Thrombectomy in Acute Stroke","Ischemic Stroke, Large Vessel Occlusion, Endovascular Treatment",null],["A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin","Diabetes",null],["A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)","SCN2A Encephalopathy, SCN8A Encephalopathy",null],["Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery","Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer",null],["An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)","Hidradenitis Suppurativa",null],["Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty","Pain",null],["A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus","Type 2 Diabetes Mellitus",null],["GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients","Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance",null],["Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging","Histiocytosis",null],["A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines","Chronic Inducible Urticaria",null],["A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer","Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma",null],["Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD","Neuromyelitis Optica Spectrum Disorder",null],["Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis","Moderate to Severe Atopic Dermatitis",null],["Veterans Affairs Seamless Phase II\u002fIII Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer","Prostate Cancer, Oligometastasis, Oligorecurrence",null],["TMS for Exposure Therapy Resistant OCD","1 Hz Real rTMS to the Pre-SMA, 1 Hz Sham rTMS to the Pre-SMA",null],["To Compare Efficacy and Safety of CMAB007 and Xolair\u00ae in Patients With Chronic Spontaneous Urticaria","Chronic Spontaneous Urticaria",null],["An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)","Thyroid Eye Disease",null],["AMX0035 and Progressive Supranuclear Palsy","Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases",null],["24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - \u003c18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up","Chronic Spontaneous Urticaria",null],["Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy","Limited Stage Small Cell Lung Cancer",null],["Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)","Burns Surgery",null],["A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors","Haemophilia A and B With and Without Inhibitors",null],["The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms","Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina",null],["Liposomal Bupivacaine Use in Alveolar Bone Graft Patients","Cleft Lip and Palate",null],["Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration","Neovascular Age-Related Macular Degeneration",null],["A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.","Generalized Anxiety Disorder",null],["Neighborhood Park Youth Sports Program Fee Waiver and Intensive Family Outreach","Physical Activity",null],["Efficacy of a Self-advocacy Serious Game Intervention","Self-Management, Quality of Life",null],["Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)","Primary Immunodeficiency Disease",null],["A Study of IL4R\u03b1 Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis","Allergic Rhinitis, Seasonal",null],["Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","Relapsing Multiple Sclerosis",null],["Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer","Breast Cancer",null],["Evaluation of Long-term Safety and Efficacy of ELX\u002fTEZ\u002fIVA in Cystic Fibrosis (CF) Participants 2 Years and Older","Cystic Fibrosis",null],["Metformin in Alzheimer's Dementia Prevention","Mild Cognitive Impairment",null],["Multi-center Trial of Ferric Derisomaltose in Children 0 to \u003c18 Years of Age With Iron Deficiency Anemia","Iron Deficiency, Anaemia in Children",null],["TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)","Non Small Cell Lung Cancer",null],["Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","Relapsing Multiple Sclerosis",null],["Ketogenic Diet for New-Onset Absence Epilepsy","Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence",null],["A Study to Determine the Safety and Efficacy of NT-501 With MHFM","Macular Telangiectasia Type 2",null],["Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes","Stem Cells, Type 1 Diabetes",null],["Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above","Tuberculosis",null],["A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)","Allergic Asthma",null],["A Study of Intra-operative Imaging in Women With Ovarian Cancer","Ovarian Cancer, Ovarian Carcinoma",null],["A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis","Psoriatic Arthritis",null],["Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers","RSV Immunisation",null],["Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","Hepatocellular Carcinoma",null],["A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+\u002fHER2- Early Breast Cancer","Early Breast Cancer",null],["Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma",null],["A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease","Thyroid Eye Disease, TED",null],["Faecal Microbiota Transplantation for Liver Cirrhosis","Liver Cirrhosis",null],["Inhaled Sevoflurane for ARDS Prevention","Acute Respiratory Distress Syndrome",null],["Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers","Sleep",null],["Phase 2\u002f3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease","Proteinuric Kidney Disease",null],["Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)","Sickle Cell Disease",null],["Comparison of Standard vs. Accelerated Corneal Crosslinking","Keratoconus, Ectasia Corneal",null],["A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer","Pancreatic Ductal Adenocarcinoma",null],["Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery","Congenital Antithrombin Deficiency",null],["Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC","Esophageal Squamous Cell Carcinoma",null],["Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)","Cardiomyopathy, Dilated",null],["A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both","Diabetes Mellitus, Type 2",null],["A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis","Plaque Psoriasis",null],["A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis","Generalized Myasthenia Gravis",null]],"hovertemplate":"phase=Phase 3\u003cbr\u003eEstimated Completion=%{x}\u003cbr\u003eTicker=%{y}\u003cbr\u003etitle=%{customdata[0]}\u003cbr\u003econdition=%{customdata[1]}\u003cbr\u003emarket_cap=%{customdata[2]}\u003cextra\u003e\u003c\u002fextra\u003e","legendgroup":"Phase 3","marker":{"color":"#EF553B","symbol":"circle"},"mode":"markers","name":"Phase 3","orientation":"v","showlegend":true,"x":["2025-12-12T00:00:00.000000000","2025-12-15T00:00:00.000000000","2025-12-15T00:00:00.000000000","2025-12-18T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-20T00:00:00.000000000","2025-12-22T00:00:00.000000000","2025-12-22T00:00:00.000000000","2025-12-22T00:00:00.000000000","2025-12-22T00:00:00.000000000","2025-12-23T00:00:00.000000000","2025-12-24T00:00:00.000000000","2025-12-25T00:00:00.000000000","2025-12-25T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-30T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2025-12-31T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-01T00:00:00.000000000","2026-01-05T00:00:00.000000000","2026-01-12T00:00:00.000000000","2026-01-15T00:00:00.000000000","2026-01-27T00:00:00.000000000","2026-01-28T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-30T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-01-31T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-01T00:00:00.000000000","2026-02-10T00:00:00.000000000","2026-02-11T00:00:00.000000000","2026-02-11T00:00:00.000000000","2026-02-12T00:00:00.000000000","2026-02-15T00:00:00.000000000","2026-02-15T00:00:00.000000000","2026-02-15T00:00:00.000000000","2026-02-18T00:00:00.000000000","2026-02-22T00:00:00.000000000","2026-02-26T00:00:00.000000000","2026-02-27T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-02-28T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-01T00:00:00.000000000","2026-03-02T00:00:00.000000000","2026-03-03T00:00:00.000000000","2026-03-05T00:00:00.000000000","2026-03-07T00:00:00.000000000","2026-03-11T00:00:00.000000000","2026-03-11T00:00:00.000000000","2026-03-15T00:00:00.000000000","2026-03-15T00:00:00.000000000","2026-03-15T00:00:00.000000000","2026-03-16T00:00:00.000000000","2026-03-18T00:00:00.000000000","2026-03-19T00:00:00.000000000","2026-03-23T00:00:00.000000000","2026-03-26T00:00:00.000000000","2026-03-27T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-30T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-03-31T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-01T00:00:00.000000000","2026-04-02T00:00:00.000000000","2026-04-15T00:00:00.000000000","2026-04-18T00:00:00.000000000","2026-04-21T00:00:00.000000000","2026-04-22T00:00:00.000000000","2026-04-24T00:00:00.000000000","2026-04-29T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-04-30T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-01T00:00:00.000000000","2026-05-03T00:00:00.000000000","2026-05-25T00:00:00.000000000","2026-05-27T00:00:00.000000000","2026-05-29T00:00:00.000000000","2026-05-29T00:00:00.000000000","2026-05-30T00:00:00.000000000","2026-05-30T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-05-31T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-01T00:00:00.000000000","2026-06-02T00:00:00.000000000","2026-06-02T00:00:00.000000000","2026-06-02T00:00:00.000000000","2026-06-05T00:00:00.000000000","2026-06-08T00:00:00.000000000"],"xaxis":"x","y":[[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],[null,0],[null,0],["CRSP",81],[null,0],[null,0],[null,0],[null,0],["ALXN",100],["MRK",100],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["AMGN",100],["MRK",100],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],["ALXN",100],[null,0],[null,0],["RHHBY",100],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],[null,0],["MRK",100],[null,0],["RHHBY",100],["ARGX",80],[null,0],[null,0],["OLMA",81],["AZN",100],[null,0],["OLMA",83],["PRAX",93],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],[null,0],["ALXN",100],[null,0],[null,0],[null,0],[null,0],["VKTX",88],["ALNY",87],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],[null,0],["VRTX",100],[null,0],[null,0],[null,0],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["SNY",100],["AZN",100],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],["VRTX",100],[null,0],[null,0],[null,0],[null,0],["AZN",100],[null,0],[null,0],[null,0],[null,0]],"yaxis":"y","type":"scatter"}],                        {"template":{"data":{"histogram2dcontour":[{"type":"histogram2dcontour","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"choropleth":[{"type":"choropleth","colorbar":{"outlinewidth":0,"ticks":""}}],"histogram2d":[{"type":"histogram2d","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"heatmap":[{"type":"heatmap","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"contourcarpet":[{"type":"contourcarpet","colorbar":{"outlinewidth":0,"ticks":""}}],"contour":[{"type":"contour","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"surface":[{"type":"surface","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"mesh3d":[{"type":"mesh3d","colorbar":{"outlinewidth":0,"ticks":""}}],"scatter":[{"fillpattern":{"fillmode":"overlay","size":10,"solidity":0.2},"type":"scatter"}],"parcoords":[{"type":"parcoords","line":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatterpolargl":[{"type":"scatterpolargl","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"bar":[{"error_x":{"color":"#2a3f5f"},"error_y":{"color":"#2a3f5f"},"marker":{"line":{"color":"#E5ECF6","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"bar"}],"scattergeo":[{"type":"scattergeo","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatterpolar":[{"type":"scatterpolar","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"histogram":[{"marker":{"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"histogram"}],"scattergl":[{"type":"scattergl","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatter3d":[{"type":"scatter3d","line":{"colorbar":{"outlinewidth":0,"ticks":""}},"marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scattermap":[{"type":"scattermap","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scattermapbox":[{"type":"scattermapbox","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatterternary":[{"type":"scatterternary","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scattercarpet":[{"type":"scattercarpet","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"carpet":[{"aaxis":{"endlinecolor":"#2a3f5f","gridcolor":"white","linecolor":"white","minorgridcolor":"white","startlinecolor":"#2a3f5f"},"baxis":{"endlinecolor":"#2a3f5f","gridcolor":"white","linecolor":"white","minorgridcolor":"white","startlinecolor":"#2a3f5f"},"type":"carpet"}],"table":[{"cells":{"fill":{"color":"#EBF0F8"},"line":{"color":"white"}},"header":{"fill":{"color":"#C8D4E3"},"line":{"color":"white"}},"type":"table"}],"barpolar":[{"marker":{"line":{"color":"#E5ECF6","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"barpolar"}],"pie":[{"automargin":true,"type":"pie"}]},"layout":{"autotypenumbers":"strict","colorway":["#636efa","#EF553B","#00cc96","#ab63fa","#FFA15A","#19d3f3","#FF6692","#B6E880","#FF97FF","#FECB52"],"font":{"color":"#2a3f5f"},"hovermode":"closest","hoverlabel":{"align":"left"},"paper_bgcolor":"white","plot_bgcolor":"#E5ECF6","polar":{"bgcolor":"#E5ECF6","angularaxis":{"gridcolor":"white","linecolor":"white","ticks":""},"radialaxis":{"gridcolor":"white","linecolor":"white","ticks":""}},"ternary":{"bgcolor":"#E5ECF6","aaxis":{"gridcolor":"white","linecolor":"white","ticks":""},"baxis":{"gridcolor":"white","linecolor":"white","ticks":""},"caxis":{"gridcolor":"white","linecolor":"white","ticks":""}},"coloraxis":{"colorbar":{"outlinewidth":0,"ticks":""}},"colorscale":{"sequential":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"sequentialminus":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"diverging":[[0,"#8e0152"],[0.1,"#c51b7d"],[0.2,"#de77ae"],[0.3,"#f1b6da"],[0.4,"#fde0ef"],[0.5,"#f7f7f7"],[0.6,"#e6f5d0"],[0.7,"#b8e186"],[0.8,"#7fbc41"],[0.9,"#4d9221"],[1,"#276419"]]},"xaxis":{"gridcolor":"white","linecolor":"white","ticks":"","title":{"standoff":15},"zerolinecolor":"white","automargin":true,"zerolinewidth":2},"yaxis":{"gridcolor":"white","linecolor":"white","ticks":"","title":{"standoff":15},"zerolinecolor":"white","automargin":true,"zerolinewidth":2},"scene":{"xaxis":{"backgroundcolor":"#E5ECF6","gridcolor":"white","linecolor":"white","showbackground":true,"ticks":"","zerolinecolor":"white","gridwidth":2},"yaxis":{"backgroundcolor":"#E5ECF6","gridcolor":"white","linecolor":"white","showbackground":true,"ticks":"","zerolinecolor":"white","gridwidth":2},"zaxis":{"backgroundcolor":"#E5ECF6","gridcolor":"white","linecolor":"white","showbackground":true,"ticks":"","zerolinecolor":"white","gridwidth":2}},"shapedefaults":{"line":{"color":"#2a3f5f"}},"annotationdefaults":{"arrowcolor":"#2a3f5f","arrowhead":0,"arrowwidth":1},"geo":{"bgcolor":"white","landcolor":"#E5ECF6","subunitcolor":"white","showland":true,"showlakes":true,"lakecolor":"white"},"title":{"x":0.05},"mapbox":{"style":"light"}}},"xaxis":{"anchor":"y","domain":[0.0,1.0],"title":{"text":"Estimated Completion"}},"yaxis":{"anchor":"x","domain":[0.0,1.0],"title":{"text":"Ticker"}},"legend":{"title":{"text":"phase"},"tracegroupgap":0},"title":{"text":"Upcoming Biotech Catalysts (Timeline)"},"height":13960},                        {"responsive": true}                    )                };            </script>        </div>
            </div>
            
            <div class="chart-container">
                <div>                            <div id="ae145d26-7e8d-41b5-90b8-6ff0f4b1665e" class="plotly-graph-div" style="height:100%; width:100%;"></div>            <script type="text/javascript">                window.PLOTLYENV=window.PLOTLYENV || {};                                if (document.getElementById("ae145d26-7e8d-41b5-90b8-6ff0f4b1665e")) {                    Plotly.newPlot(                        "ae145d26-7e8d-41b5-90b8-6ff0f4b1665e",                        [{"customdata":[["Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer","Advanced Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma",0.0],["Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery","Pancreatic Adenocarcinoma",0.0],["UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study","Type 2 Diabetes Mellitus (T2DM)",0.0],["ASA in Prevention of Ovarian Cancer (STICs and STONEs)","Ovarian Cancer Prevention",0.0],["Dendritic Cell Vaccines Against Her2\u002fHer3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer","Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Triple-Negative Breast Carcinoma",0.0],["Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML","Acute Myeloid Leukemia",0.0],["Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer","Anal Cancer",0.0],["Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer","Locally Advanced Adrenal Cortex Carcinoma, Adrenal Cortical Carcinoma, Stage III Adrenal Cortex Carcinoma",0.0],["Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant","Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm",0.0],["A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer","Breast Cancer",0.0],["CD19 & CD20 Bispecific CAR T Cells for Relapsed \u002f Refractory B Cell Hematological Tumors","B-Cell Lymphoblastic Leukemia\u002fLymphoma",0.0],["Serplulimab Combined with CAPEOX + Celecoxib As Neoadjuvant Treatment for Locally Advanced Rectal Cancer","PMMR, MSS, MSI-L",0.0],["Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients","Parkinson Disease, Anxiety",0.0],["A Study of RAY1225 in Participants With Type 2 Diabetes","T2DM (Type 2 Diabetes Mellitus)",0.0],["Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer","Colorectal Cancer",0.0],["Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders","AML, ALL, MDS",0.0],["A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease","Crohn Disease, Colitis, Ulcerative",0.0],["A Phase 1\u002f2 Study of IDP-121 in Patients With Relapsed\u002fRefractory Hematologic Malignancies","Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double Hit Lymphoma",0.0],["A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma","Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma",0.0],["Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab","Solid Tumor, Metastases to Soft Tissue",0.0],["Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)","Intracerebral Hemorrhage",0.0],["Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia","B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt-Like Lymphoma With 11q Aberration",0.0],["Study of Trilaciclib and Lurbinectidin","Lung Cancer, Small-cell Lung Cancer",0.0],["Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigmentation","Post Burn Facial Hyperpigmentation",0.0],["Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I\u002fII\uff0cMulti-center, Clinical Study.","Neuroblastoma",0.0],["A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab","Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma",0.0],["Feasibility of Semaglutide in Advanced Lung Disease","Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease",0.0],["The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial","Tinnitus",0.0],["A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2\u002fNeu Positive (HER2+) Breast Cancer (BC)","Breast Cancer, HER2-positive",0.0],["Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis","Atopic Dermatitis",0.0],["A Study of MIL62 Combined With Orelabrutinib for the Treatment of R\u002fR CD20+B Cell Lymphoma","B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory",0.0],["A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors","Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma",0.0],["RFA Plus Carrizumab vs Carrizumab Alone for HCC","Tumor Immunity, Immunosuppression, Radiofrequency Ablation",0.0],["Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)","Primary Immune Thrombocytopenia",0.0],["Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)","Advanced Biliary Tract Cancer",0.0],["A Study to Evaluate in Patients With Parkinsonian Type Disorders","Idiopathic Parkinson Disease",0.0],["Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)","Advanced Intrahepatic Cholangiocarcinoma",0.0],["NT-101 Topical Ophthalmic Solution in Patients With Wet AMD","Wet Age Related Macular Degeneration, Wet AMD",0.0],["Cisplatin+Pembrolizumab+RT in Vulvar Cancer","Vulvar Cancer, Vulvar Squamous Cell Carcinoma",0.0],["Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes","Asthma, Obesity",0.0],["VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma","Myeloma, Newly Diagnosed, High Risk",0.0],["Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients","End Stage Renal Disease on Dialysis, Hemodialysis, Peritoneal Dialysis",0.0],["Adriamycin and Ifosfamide Combined With Sintilimab","Soft Tissue Sarcoma",0.0],["Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)","Cutaneous Breast Cancer",0.0],["Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma","Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E\u002fK Mutated",0.0],["Serplulimab Plus Chemotherapy for Early-stage HR+\u002fHER2- Breast Cancer","Breast Cancer",0.0],["Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer \uff08CASTLE-08\uff09","Advanced Biliary Tract Cancer",0.0],["Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma","Kidney Cancer, Renal Cell Carcinoma, Renal Clear Cell Carcinoma",0.0],["Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab","Pulmonary Fibrosis",0.0],["Terazosin Effect on Cardiac Changes in Early Parkinson's Disease","REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease",0.0],["Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis","Pneumonitis",0.0],["Rapid Improvement of Depression of Fluoxetine Combined With ATP","Depression",0.0],["Spinal Cord Neuromodulation for Spinal Cord Injury","Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia",0.0],["Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel\u002fCarboplatin in Fertility Preserving Surgery","Neoadjuvant Immunotherapy, Cervical Cancer, Fertility-sparing Surgery",0.0],["Pembrolizumab in Hepatocellular Carcinoma","HCC",0.0],["Ertugliflozin in Chronic Heart Failure","Heart Failure",0.0],["A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)","Relapsed or Refractory Acute Myeloid Leukemia (AML)",0.0],["Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)","Solid Tumor, Adult",0.0],["Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies","Hematologic Malignancies",0.0],["Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)","Hepatocellular Carcinoma",0.0],["A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer","Prostate Cancer",0.0],["Phase II Clinical Trial of Interleukin-2 in AD","Alzheimer Disease",0.0],["A Study of Tucatinib and Trastuzumab in People With Rectal Cancer","Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma",0.0],["A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma","Lymphoma",0.0],["A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody","Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer",0.0],["A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors","PD-L1-selected Solid Tumors",0.0],["LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer","Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma",0.0],["Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer","Breast Neoplasm Female, Metastatic Breast Cancer",0.0],["Dapagliflozin in Allo-HCT for aGVHD","Graft-versus-host Disease (GVHD)",0.0],["PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients","Acute Lung Injury, Prevention",0.0],["Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed","Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes",0.0],["Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed\u002fRefractory Hodgkin Lymphoma","Hodgkin Lymphoma",0.0],["GD2\u002fCD70 Bi-specific CAR-T Cell Therapy","Cancer Disease",0.0],["Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4\u002f6 Inhibitor","Advanced Breast Cancer",0.0],["Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study","Tuberous Sclerosis Complex, Epilepsy",0.0],["Caplyta in Borderline Personality Disorder","Borderline Personality Disorder",0.0],["Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma","Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma",0.0],["Effects of Mirtazapine on Appetite in Advanced Cancer Patients","Advanced Cancer, Anorexia, Weight Loss",0.0],["Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy","Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm",0.0],["CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies","T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia",0.0],["Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma","Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma",0.0],["Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)","Renal Cell Carcinoma (RCC)",0.0],["Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma","Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma",0.0],["Trimodality Therapy With\u002fOut Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer","Bladder Cancer",0.0],["Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma","Esophageal Cancer, Nimotuzumab, Chemoradiotherapy",0.0],["Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients","Stroke, Stroke, Ischemic, Stroke; Sequelae",0.0],["A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer","Extensive-stage Small Cell Lung Cancer",0.0],["Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC","Hepatocellular Carcinoma Non-resectable, HCC",0.0],["HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM","Glioblastoma, Anaplastic Astrocytoma",0.0],["Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM","Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes",0.0],["Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss","Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma",0.0],["Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas","T-Cell Lymphoma",0.0],["Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients","Breast Cancer Female",0.0],["Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma","Primary Central Nervous System Lymphoma",0.0],["A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease","Stable Coronary Artery Disease CAD",0.0],["Low Dose IL-2 for the Treatment of Crohn's Disease","Crohn Disease",0.0],["PSMA\u002fCD70 Bi-specific CAR-T Cell Therapy","Cancer Disease",0.0],["Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans","Post Traumatic Stress Disorder, Opioid-use Disorder",0.0],["Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction","Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Persistent Disease, Refractory Acute Myeloid Leukemia",0.0],["Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease","Sickle Cell Disease, Diffuse Myocardial Fibrosis",0.0],["Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients","Esophageal Cancer, Nimotuzumab, Chemoradiotherapy",0.0],["Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease","Parkinson Disease",0.0],["A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC","Esophageal Squamous Cell Carcinoma",0.0],["A Clinical Study of T3011 in Combination With PD-1\u002fPD-L1 Inhibitors in Subjects With Advanced Solid Tumors","Advanced Solid Tumors",0.0],["GD2\u002fCD56 Bi-specific CAR-T Cell Therapy","Malignant Disease",0.0],["Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies","Solid Organ Malignancies",0.0],["Minocycline for Chronic Autoimmune Uveitis","Minocycline, Uveitis, Retinal Degeneration",0.0],["a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors","Solid Tumor",0.0],["Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model","Acute Graft-versus-Host Disease",0.0],["Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder","Urothelial Carcinoma, Bladder Cancer",0.0],["Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2","Alcohol Use Disorder, Hiv, Tobacco Use Disorder",0.0],["Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis","Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis",0.0],["Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors","Advanced Solid Tumor",0.0],["Ramucirumab + Pembrolizumab in Patients With Recurrent\u002fMetastatic Head and Neck Squamous Cell Carcinoma","Head and Neck Squamous Cell Carcinoma",0.0],["Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers","Cigarette Smoking-Related Carcinoma",0.0],["Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment","Nasopharyngeal Cancer",0.0],["A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia","Immune Thrombocytopenia, Treatment",0.0],["Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1\u002fPD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma","Esophageal Malignant Neoplasm Primary",0.0],["Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer","Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer",0.0],["PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors","Locally Advanced or Metastatic Solid Tumors",0.0],["Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma (NPC)",0.0],["Effect Camostat for Kidney Protection in Chronic Kidney Disease","Chronic Kidney Disease(CKD)",0.0],["Nanobody-Based CD19\u002fCD22 Tandem Dual CAR-T Therapy for R\u002fR B-ALL","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma",0.0],["FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma","Head and Neck Squamous Cell Carcinoma",0.0],["5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial","Intra-abdominal Cancer",0.0],["Comparing Chemotherapy With\u002fWithout Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma",0.0],["A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation","Metastatic Castration Resistant Prostate Cancer",0.0],["Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN","Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm",0.0],["Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment","Non Small Cell Lung Cancer, Perioperative Complication",0.0],["Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks","Postoperative Pain, Nausea and Vomiting, Postoperative, Dizziness",0.0],["IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer","Platinum-resistant Ovarian Cancer",0.0],["Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma",0.0],["Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder","Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder",0.0],["Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer","Prostate Cancer",0.0],["An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC","Mpox (Monkeypox)",0.0],["A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol","Alcohol Use Disorder",0.0],["Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study","Advanced Hepatocellular Carcinoma",0.0],["Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer","Pancreatic Neoplasms",0.0],["HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged \u22652 Years With Congenital Hyperinsulinism (CHI)","Congenital Hyperinsulinism",0.0],["Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.","Ovarian Neoplasms, Ovarian Diseases",0.0],["4FMFES-PET Imaging of ER+ Advanced Breast Cancers","ER+ Breast Cancer",0.0],["Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer","Non-small Cell Lung Cancer",0.0],["Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia","Covid-19, Sars-CoV2, Pneumonia",0.0],["Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes","Advanced Malignant Neoplasm, ATM Gene Mutation, BRCA1 Gene Mutation",0.0],["Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD","Chronic Kidney Diseases, Metabolic Acidosis, Fatigue",0.0],["MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia","Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease",0.0],["Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment","Malignant Fungating Wound",0.0],["A Phase Ib\u002fII Study of SHR-A1811 Injection in Breast Cancer","Breast Cancer",0.0],["Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)","PTSD",0.0],["A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma","Melanoma",0.0],["Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable\u002fMetastatic Colorectal Cancer","Unresectable\u002fMetastatic Colorectal Cancer",0.0],["A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors","Solid Tumor",0.0],["A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs","Unresectable Gallbladder Cancer",0.0],["Phase II Trial of Sacituzumab Govitecan in Recurrent and\u002for Metastatic Secretory Gland Cancers","Gland, Salivary Gland Cancers",0.0],["Phase 2b Controlled Study of Dosing Techniques - Part B","Dry Eye",0.0],["Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction","Breast Cancer, Heart Failure",0.0],["Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy","Alzheimer Disease",0.0],["Vorinostat in Treating Patients With Metastatic Melanoma of the Eye","Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7",0.0],["Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)","DLBCL",0.0],["A Study of EXG102-031 in Participants With wAMD","Neovascular Age-related Macular Degeneration",0.0],["Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma","Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma",0.0],["IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus","Pemphigus",0.0],["\"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS\u002fpMMR Colorectal Cancer\"","MCRC",0.0],["Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery","Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8",0.0],["Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation","Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy",0.0],["Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel","Healthy Adults",0.0],["Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT","PCNSL",0.0],["Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia","Erythroplakia, Oral Leukoplakia",0.0],["A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG","Gastric\u002fGastroesophageal Junction Adenocarcinoma",0.0],["Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers","Metastatic Malignant Female Reproductive System Neoplasm",0.0],["Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously","Erectile Dysfunction",0.0],["Frontline Oral Arsenic Trioxide for APL","Acute Promyelocytic Leukemia",0.0],["Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness","Asthma, Wheezing",0.0],["Fedratinib in Combination with Nivolumab","Primary Myelofibrosis, Secondary Myelofibrosis",0.0],["Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)","Assisted Reproduction",0.0],["Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer","Non-small Cell Lung Cancer",0.0],["Proton Beam Therapy for Chordoma Patients","Chordoma",0.0],["Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC","EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma",0.0],["Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma","Mesenchymal Chondrosarcoma",0.0],["Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma","Classical Hodgkin Lymphoma",0.0],["Everolimus Aging Study","Aging, Insulin Resistance",0.0],["A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon\u00ae, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation\u002fFlutter After Terminating Its Persistent Form","Atrial Fibrillation, Atrial Flutter",0.0],["Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT","Ocular Graft-versus-host Disease",0.0],["Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension","Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease",0.0],["A Phase I Study of Mozobil in the Treatment of Patients With WHIMS","Leukopenia, Neutropenia, Infections",0.0],["Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial","Cavernous Malformations, Intracerebral Hemorrhage, Brainstem Stroke",0.0],["A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)","Atrial Fibrillation",0.0],["Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)","Esophagus Cancer",0.0],["Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer","Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8",0.0],["Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck","Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx",0.0],["Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)","Acute Myeloid Leukemia",0.0],["A Phase Ib\u002fII Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC","Non-Small Cell Lung Cancer With EGFR Mutation",0.0],["A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders","Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL",0.0],["Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1\u002f2\u002f3 (Trk A\u002fB\u002fC), ROS1, or ALK Gene Rearrangements (Fusions)","Breast Cancer, Cholangiocarcinoma, Colorectal Cancer",0.0],["SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies","Anemia",0.0],["Phase 2b Controlled Study","Dry Eye Disease",0.0],["TB006 for Autism Spectrum Disorder","Autism Spectrum Disorder",0.0],["A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma","Metastatic Urothelial Carcinoma",0.0],["Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV","Gram Negative Pneumonia, Gram-Negative Bacterial Infections, Bacteremia Caused by Gram-Negative Bacteria",0.0],["Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer","Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation",0.0],["A Study of NTRX-07 in Participants With Alzheimer's Disease","Alzheimer Disease, Mild Cognitive Impairment",0.0],["RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.","ALL, Adult, Philadelphia-Negative ALL",0.0],["RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)","Long COVID, Long COVID-19, Hypersomnia",0.0],["FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer","Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic",0.0],["Amantadine Therapy for Cognitive Impairment in Long COVID","Long COVID, Post-COVID19 Condition, Post-Acute COVID19 Syndrome",0.0],["Doxycycline to Protect Heart Muscle After Heart Attacks","ST Segment Elevation Myocardial Infarction, Heart Failure",0.0],["Efficacy and Safety of AC102 Compared to Steroids in Adults with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)","Hearing Loss, Sensorineural",0.0],["Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy","Pneumonia, Critically Ill",0.0],["Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas","Glioblastoma, Recurrent, Lower Grade Glioma, Recurrent",0.0],["Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer","NSCLC, Neoadjuvant Therapy",0.0],["A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules","Progression",0.0],["Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer","Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma",0.0],["CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory\u002fRelapsed Aggressive Non-Hodgkin's Lymphoma (NHL).","Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma",0.0],["Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant","Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia",0.0],["Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer","Metastatic Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma, RAS Mutation",0.0],["Cardamom and Topical Roseomonas in Atopic Dermatitis","Atopic Dermatitis, Eczema",0.0],["Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and\u002for Refractory Multiple Myeloma","Multiple Myeloma",0.0],["Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer","Gastric Cancer",0.0],["ENB003 Plus Pembrolizumab Phase 1b\u002f2a in Solid Tumors","Cancer, Melanoma, Ovary Cancer",0.0],["TheraT\u00ae Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers","Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma",0.0],["Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation","Inflammatory Disease, Aging Problems, Obese",0.0],["Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma","Esophagogastric Junction Adenocarcinoma",0.0],["Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients","Stroke Rehabilitation, Gait Disorders, Neurologic, tDCS",0.0],["Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy","Ischemic Heart Disease",0.0],["Intrathecal Combination of Programmed Death-1 (PD-1)\u002fCytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis","Leptomeningeal Metastasis",0.0],["Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)","Multiple Sclerosis",0.0],["Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT","Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety",0.0],["Vaginal Baclofen Suppositories in Chronic Pelvic Pain","Chronic Pelvic Pain Syndrome",0.0],["(Neo)Adjuvant BRAF\u002fMEK Inhibition in pN1c Melanoma","Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma",0.0],["A Study to Evaluate CM336 in Adults with Autoimmune Bullous Disease","Autoimmune Bullous Disease",0.0],["Alpha\u002fBeta TCD HCT in Patients With Inherited BMF Disorders","Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes",0.0],["5HTP Regulation Of Asthma In Children","Mild or Moderate Asthma With Allergic Sensitization",0.0],["Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma","Grade 2 Meningioma, Grade 3 Meningioma, Recurrent Meningioma",0.0],["Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia","Fibrous Dysplasia",0.0],["A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines","Malaria, Malaria,Falciparum, Parasitic Disease",0.0],["A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia","Chronic Lymphocytic Leukemia, COVID-19 Infection",0.0],["The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients","Anterior Cruciate Ligament Reconstruction",0.0],["Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis","Metastatic Malignant Neoplasm in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7",0.0],["Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma","Classical Hodgkin Lymphoma",0.0],["Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients","Sepsis",0.0],["CAR- PRISM (PRecision Intervention Smoldering Myeloma)","Multiple Myeloma, Smoldering Multiple Myeloma",0.0],["Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia","Acute Myeloid Leukemia, Myelodysplastic Syndrome",0.0],["A Phase I\u002fII Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)","Influenza A",0.0],["Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer","Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer",0.0],["A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery","Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8",0.0],["Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)","Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, Advanced Intrahepatic Cholangiocarcinoma",0.0],["A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors","Advanced or Metastatic Solid Tumors",0.0],["The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures","Disease or Disorder",0.0],["Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)","Postural Orthostatic Tachycardia Syndrome (POTS)",0.0],["Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma","Asthma",0.0],["Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis","Primary Biliary Cholangitis",0.0],["R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse","Diffuse Large B-cell Lymphoma",0.0],["Treatment of Moderate to Severe Refractory Crohn's Disease","Crohns Disease",0.0],["Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma","Diffuse Large B-Cell Lymphoma",0.0],["Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.","Hidradenitis Suppurativa",0.0],["Trilaciclib Prevents Myelosuppression With Chemoradiotherapy","Myelosuppression",0.0],["Study of ODX (OsteoDex) in Multiple Myeloma","Multiple Myeloma",0.0],["Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury","Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System",0.0],["Acalabrutinib in CNSL","Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma, Recurrent Central Nervous System Lymphoma",0.0],["Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia","Sickle Cell Anemia, Beta Thalassemia",0.0],["Further MT for Antibiotic-Resistant Bacterial Colonization in Inpatients","Multi-drug Resistant Organism",0.0],["The Effect of Sulfasalazine on CRH Levels in Pregnant Women","Preterm Birth",0.0],["Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer","EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation",0.0],["CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children","Pharmacokinetics of Celecoxib in Children",0.0],["Milk Thistle Clinical Trial in Pediatric NAFLD","Non-Alcoholic Fatty Liver Disease (NAFLD)",0.0],["Intravenous Estrogen in Kidney Transplant Study","Ischemia Reperfusion Injury",0.0],["SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)","CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Lymphomatoid Papulosis",0.0],["Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC","Spinal Disease",0.0],["Atezolizumab + Cabozantinib in Patients w\u002f Metastatic, Refractory Pancreatic Cancer","Pancreatic Cancer, Metastatic Pancreatic Cancer",0.0],["Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia","Aplastic Anemia, TPO Receptor Agonists",0.0],["Venetoclax After TKI to Target Persisting Stem Cells in CML","Chronic Myeloid Leukemia",0.0],["A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity","Hypothalamic Obesity",0.0],["A Study in Subjects With Neurogenic Orthostatic Hypotension","Neurogenic Orthostatic Hypotension",0.0],["Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes","Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk",0.0],["BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC","Triple-Negative Breast Cancer (TNBC), Brain Metastases",0.0],["Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic \" Patient Reported Outcome \") on Breast-related Quality of Life","Breast Cancer",0.0],["An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia","Immune Thrombocytopenia (ITP), Treatment",0.0],["A Phase 1\u002f2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer","Non Small Cell Lung Cancer, EGFR Exon 20 Mutation",0.0],["Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed\u002fRefractory Acute Myeloid Leukemia","Relapsed\u002fRefractory Acute Myeloid Leukemia",0.0],["Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL","Diffuse Large B Cell Lymphoma",0.0],["Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers","Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer",0.0],["A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme","Glioblastoma Multiforme, Adult",0.0],["Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma","Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and\u002for BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements",0.0],["The Impact of a Virtual Magic Trick Training Program","Autism, Pervasive Developmental Disorder",0.0],["Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery","Malignant Neoplasms of Female Genital Organs, Ovarian Cancer, Fallopian Tube Cancer",0.0],["Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer","Rectal Cancer",0.0],["Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression","Bipolar Disorder, Bipolar Depression, Bipolar I Disorder",0.0],["A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia","Leukemia",0.0],["A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis","Immune-related Colitis, Colitis",0.0],["A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors","Advanced Solid Tumor",0.0],["Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment","Colorectal Cancer",0.0],["Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas","Salivary Gland Cancer, HER2 Gene Mutation",0.0],["Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa","HIV I Infection, Tuberculosis",0.0],["Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)","Sarcoma, Radiosurgery",0.0],["Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD","Autism Spectrum Disorder (ASD)",0.0],["A Study of Immune Suppression Treatment for People With Sickle Cell Disease or \u03b2-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","Sickle Cell Disease, Thalassemia, Beta, Thalassemia",0.0],["Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought","Healthy",0.0],["Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes","Type 1 Diabetes, Diabetes Mellitus, Type 1",0.0],["Phase II Study of THDBH120 Injection in Overweight or Obese Subjects","Overweight or Obese",0.0],["A Phase 1\u002f2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)","Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia",0.0],["A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults","Shingles, Herpes Zoster Infection, Human",0.0],["Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis","Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation",0.0],["NP137 Clinical and Biological Activities Assessment in Patients With Advanced\u002fMetastatic Solid Tumors Treated by Standard Anti PD-1\u002fPD-L1 Immunotherapies","Advanced Solid Tumors, Metastatic Solid Tumors",0.0],["A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure","Chronic Heart Failure",0.0],["A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies","Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia",0.0],["Neurocognitive Decline in Patients With Brain Metastases","Brain Metastases",0.0],["Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation","Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8",0.0],["Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed\u002fRefractory Peripheral T Cell Lymphoma","Relapsed\u002fRefractory Peripheral T Cell Lymphoma",0.0],["Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?","Alcohol Drinking",0.0],["Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis","Idiopathic Pulmonary Fibrosis (IPF)",0.0],["A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)","Neuromyelitis Optica Spectrum Disorders",0.0],["A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.","Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations",0.0],["Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage","Herpes Zoster (HZ)",0.0],["The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors","Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL), AML (Acute Myelogenous Leukemia), Myeloma Multiple",0.0],["A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults","Psoriasis (PsO)",0.0],["Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma","Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma",0.0],["Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors","Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma",0.0],["BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study","Bipolar Disorder, Depressive Episode",0.0],["A Study of AT-02 in Subjects With Systemic Amyloidosis.","Amyloidosis; Systemic",0.0],["Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer","Colon Cancer",0.0],["Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis","MRI-guided Adaptive Radiotherapy, Non-small Cell Lung Cancer, Brain Metastasis",0.0],["A Study of IBI363 in Subjects with Advanced Solid Malignancies","Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer",0.0],["Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI","STEMI, STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction (MI)",0.0],["STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer","Malignant Neoplasm of Prostate, Locally Advanced Prostate Cancer",0.0],["TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)","Breast Cancer",0.0],["Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms","Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome",0.0],["Chemotherapy (DA-EPOCH+\u002f-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia","B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0.0],["Nodular Shrinking in Dupuytren Disease","Dupuytren's Disease",0.0],["Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib","Multiple Myeloma in Relapse, Refractory Multiple Myeloma",0.0],["Lactobacillus Johnsonii in Children and Adolescents With T1D","Type 1 Diabetes (T1D)",0.0],["Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w\u002f Metastatic PAC","Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma",0.0],["Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients","Inflammatory Response After Surgery, Postoperative Recovery",0.0],["Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy","CMV",0.0],["Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer","Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy",0.0],["Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2","Clear Cell Renal Cell Carcinoma, Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Malignant Solid Neoplasm",0.0],["A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS","Advanced Solid Tumors",0.0],["A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS","Acute Ischemic Stroke AIS",0.0],["Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee","Subchondral Insufficiency Fracture",0.0],["Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment","Advanced NSCLC",0.0],["Study of Intra-articular Allocetra in Knee Osteoarthritis","Osteoarthritis, Knee",0.0],["Efficacy and Safety of 500mg of Fulvestrant","Breast Cancer",0.0],["Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases","Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer",0.0],["First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors","Advanced Solid Tumor, Metastatic Solid Tumor",0.0],["A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome","Sjogren's Syndrome",0.0],["Pembrolizumab in Treating Patients With Malignant Mesothelioma","Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma",0.0],["Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r\u002fr B-NHL","Non-hodgkin Lymphoma,B Cell",0.0],["Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy","Anaplastic Thyroid Cancer",0.0],["GEN1047 for Solid Tumors - First in Human (FIH) Trial","Breast Cancer, Breast Neoplasms, Endometrial Cancer, Endometrial Neoplasm, Ovarian Cancer, Ovarian Neoplasms",0.0],["A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)","Systemic Lupus Erythematosus",0.0],["Post-operative Urinary Retention (POUR) Following Thoracic Surgery","Urinary Retention",0.0],["Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome","Acute Coronary Syndrome",0.0],["Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients","Non-squamous NSCLC",0.0],["Clinical Trial on Agitation in Alzheimer's Dementia","Alzheimer Disease, Agitation,Psychomotor, Care Giving Burden",0.0],["APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors","Solid Tumors, Advanced Cancer, Renal Cancer",0.0],["A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures","Epilepsy, Generalized, Epilepsy, Absence",0.0],["Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI","Non Small Cell Lung Cancer",0.0],["ATORvastatin in Pulmonary TUBerculosis","Pulmonary Tuberculosis, Tuberculosis, Koch's Disease",0.0],["Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy","Sepsis, Severe",0.0],["Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.","Muscle Atrophy",0.0],["rTMS to Improve Cognition in Parkinson's","Parkinson's Disease, Mild Cognitive Impairment",0.0],["A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy","Melanoma",0.0],["A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease","Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)",0.0],["Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)","Rift Valley Fever",0.0],["CERebrolysin In CADASIL","Cadasil",0.0],["Antibiotic Prophylaxis for Neurogenic Bladder Botox","Neurogenic Bladder, Post-operative Urinary Tract Infections",0.0],["Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia","Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma",0.0],["A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer","Rectal Cancer",0.0],["A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma","Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma",0.0],["Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma","Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer",0.0],["A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT","Acute Ischemic Stroke",0.0],["Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia","Aggressive NK Cell Leukemia",0.0],["An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations","Brain Arteriovenous Malformations",0.0],["Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation","Hemodialysis",0.0],["A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer","Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer",0.0],["Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant","Allogeneic Stem Cell Transplantation",0.0],["Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease","Chronic Kidney Diseases",0.0],["Phase 2 Study of Dacomitinib in NSCLC","NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV",0.0],["Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial)","Pain, Neuropathic Pain, Irritability",0.0],["Study of the CDK4\u002f6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6","Cancer",0.0],["A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy","Minimal Residual Disease, Adjuvant Chemotherapy, Colorectal Cancer",0.0],["Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies","T-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia",0.0],["RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)","Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19",0.0],["A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)","Juvenile Idiopathic Arthritis",0.0],["Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia","Schizophrenia",0.0],["CD7 CAR T-Cell Therapy for r\u002fr T-cell Lymphomas","T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)",0.0],["Targeted Naltrexone to Support Individuals Participating in Dry January","Alcohol Misuse",0.0],["Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients","Metastatic Renal Cell Carcinoma",0.0],["Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)","Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Metabolic Dysfunction-Associated Steatohepatitis",0.0],["Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer","Prostate Cancer",0.0],["NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial","Metastatic Breast Cancer",0.0],["DOR\u002fTDF\u002f3TC Switch With M184V\u002fI in People With Controlled HIV (Drive Off-Road)","Hiv",0.0],["Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)","Overweight, Type 2 Diabetes, Obesity",0.0],["A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis","Moderate to Severe Ulcerative Colitis",0.0],["Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells","Unresectable Hepatocellular Carcinoma",0.0],["A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors","Advanced Solid Tumors",0.0],["A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer","Metastatic Colorectal Cancer",0.0],["Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage","Sub-arachnoid Haemorrhage",0.0],["Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","Norovirus Acute Gastroenteritis",0.0],["Novel MGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes","Alcohol Use Disorder",0.0],["A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer","Advanced Metastatic Castration Resistant Prostate Cancer",0.0],["Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study","Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma",0.0],["Radical Concurrent Chemoradiotherapy With DDP\u002f5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma","Rectal Squamous Cell Carcinoma",0.0],["Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B\u002fKEYMAKER-U02)","Melanoma",0.0],["Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma","Hepatocellular Carcinoma",0.0],["Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma","Craniopharyngiomas",0.0],["A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma","Hematologic Malignancies",0.0],["A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer","Esophageal Cancer, Dysphagia, Esophageal, Epigallocatechin Gallate",0.0],["A Modular Phase 1\u002f2 Study With CT7439 in Participants With Solid Malignancies","Solid Malignancies",0.0],["A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity","Obesity or Overweight",0.0],["Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial","Chronic Rhinosinusitis (CRS)",0.0],["CD7 CAR-T Bridging to alloHSCT for R\u002fR CD7+Malignant Hematologic Diseases","Hematologic Diseases, Neoplasms",0.0],["Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)","Multiple Myeloma",0.0],["A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy","Chemotherapy-induced Peripheral Neuropathy",0.0],["A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer","Pancreatic Cancer",0.0],["Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy","Carcinoma, Non-Small-Cell Lung",0.0],["TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)","Breast Cancer",0.0],["Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer","Triple-negative Breast Cancer, Cadonilimab",0.0],["Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy","Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes",0.0],["An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection","Influenza, Human, Arthralgia",0.0],["Dopaminergic Dysfunction in Late-Life Depression","Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant",0.0],["A Phase Ib\u002fII Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC","Malignant Pleural Effusions, NSCLC Stage IV",0.0],["Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)","Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset",0.0],["Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240\u002fPRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)","Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease",0.0],["A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)","Metabolic Dysfunction-associated Steatohepatitis (MASH)",0.0],["Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis","Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8",0.0],["Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma","Grade I Meningioma, Adult, Grade II Meningioma, Adult, Grade III Meningioma, Adult",0.0],["Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis\u002fChronic Fatigue Syndrome","Chronic Fatigue Syndrome, Myalgic Encephalomyelitis",0.0],["a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia","Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib",0.0],["Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)","Asthma With Allergic Rhinitis",0.0],["Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)","Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair",0.0],["Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)","Parkinson Disease",0.0],["A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","Non-Small Cell Lung Cancer",0.0],["Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR\u002fMSS LARC.","Rectal Cancer Patients",0.0],["A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils","Chronic Obstructive Pulmonary Disease (COPD)",0.0],["Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma",0.0],["Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer","Breast Cancer Female, Hormone Receptor Positive Tumor",0.0],["Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure","Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown",0.0],["Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome","PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries",0.0],["Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy","Lymphoma, Follicular Lymphoma, Lymphoma,Non-Hodgkin",0.0],["Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma","Locally Advanced Thymoma",0.0],["RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients","Bladder Cancer, Muscle-Invasive Bladder Carcinoma",0.0],["A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma","Newly Diagnosed Diffuse Large B-cell Lymphoma",0.0],["Vitiligo Treatment by Targeting TYK2 Mediated Responses","Vitiligo, Generalized",0.0],["Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.","PNH - Paroxysmal Nocturnal Hemoglobinuria",0.0],["A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer","Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms",0.0],["The Communicate Study Partnership","Aboriginal Health, Cultural Safety, Access to Interpreters",0.0],["Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer","Metastatic Castrate-Resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)",0.0],["A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer","Metastatic Colorectal Cancer",0.0],["Beetroot Juice NO Cold Study","Respiratory Tract Infections, Cold Symptoms, Exhaled Nitric Oxide",0.0],["A Phase \u2160b\u002f\u2161 Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML","Acute Myeloid Leukemia, Adult",0.0],["Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.","Diabetic Foot Ulcer, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)",0.0],["Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease","Diabetic Kidney Disease (DKD)",0.0],["Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder","Autism Spectrum Disorder",0.0],["Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer","Head and Neck Squamous Cell Carcinoma",0.0],["A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric\u002fGastroesophageal Junction Adenocarcinoma","Gastric\u002fGastroesophageal Junction Adenocarcinoma",0.0],["Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI","Posttraumatic Headache, Mild Traumatic Brain Injury",0.0],["Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98\u002fKEYNOTE-B98)","Small Cell Lung Carcinoma",0.0],["COAST Therapy in Advanced Solid Tumors and Prostate Cancer","Prostate Cancer Recurrent, Solid Tumor, Adult",0.0],["Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases","Breast Cancer Stage IV",0.0],["A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults","Pneumococcal Disease",0.0],["Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","Chronic Lymphocytic Leukemia\u002fSmall Lymphocytic Lymphoma",0.0],["Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects","Bronchial Asthma",0.0],["Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML","Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)",0.0],["Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors","Cancer, Remission",0.0],["ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer","Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma",0.0],["Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age","Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis",0.0],["D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)","Major Depressive Disorder",0.0],["A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma","Follicular Lymphoma, Marginal Zone Lymphoma",0.0],["Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy","Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm",0.0],["Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed\u002fRefractory Diffuse Large B-cell Lymphoma","Diffuse Large B Cell Lymphoma",0.0],["Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent\u002fMetastatic Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma by AJCC V8 Stage",0.0],["Reducing Innate Inflammation in New Onset Type 1 Diabetes","Type 1 Diabetes, type1diabetes, Type 1 Diabetes Mellitus",0.0],["Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia","Dyslipidemias",0.0],["Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma","Multiple Myeloma, Myeloma Multiple, Kahler Disease",0.0],["A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)","Myelofibrosis",0.0],["A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke","Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke",0.0],["CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease","Systemic Lupus Erythematosus, Systemic Sclerosis, Dermatomyositis",0.0],["RNS System LGS Feasibility Study","Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable",0.0],["BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r\u002fr B-ALL","Acute Lymphocytic Leukemia",0.0],["Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)","Mantle Cell Lymphoma",0.0],["OSU6162 as add-on in SSRI\u002fSNRI-resistant Depression","Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder",0.0],["Migraine Manager (R01)","Migraine, Migraine Disorders",0.0],["Effect of Belimumab on Antibody Titers in Primary APS Patients","Antiphospholipid Syndrome (APS)",0.0],["Fluzoparib Neoadjuvant Therapy for Ovarian Cancer","Ovarian Cancer",0.0],["A Phase 1b\u002f2a, Study Evaluating the Safety, PK\u002fPD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients","Seneorineural Deafness, Sudden Sensorineural Hearing Loss",0.0],["R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia","Waldenstr\u00f6m's Macroglobulinemia",0.0],["The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM","Gastric Cancer, Metastatic",0.0],["Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia","Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Biphenotypic Leukemia",0.0],["Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer","Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8",0.0],["Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)","Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8",0.0],["A Phase \u2161 Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC","Non-Small Cell Lung Cancer",0.0],["A Single-arm, Prospective Phase \u2161 Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC","Metastatic Breast Cancer",0.0],["Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (\u00b1 Navitoclax) in Relapsed\u002fRefractory Mantle Cell Lymphoma","Mantle Cell Lymphoma Refractory",0.0],["A Window-of-Opportunity Trial of Giredestrant +\u002f- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive\u002fHER2-negative Early Breast Cancer","Breast Cancer",0.0],["Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage","Giant Cell Tumor of Bone",0.0],["To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer","Non-Small Cell Lung Cancer",0.0],["Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.","Marginal Zone Lymphoma",0.0],["A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC","Intrahepatic Cholangiocarcinoma (Icc)",0.0],["CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome","Acute Myeloid Leukemia With Gene Mutations, Myelodysplastic Syndrome, Myeloproliferative Neoplasm",0.0],["Cabozantinib Combined With Ipilimumab\u002fNivolumab and TACE in Patients With Hepatocellular Carcinoma","Hepatocellular Carcinoma, HCC",0.0],["Pharmacogenomics for Better Treatment of Fungal Infections in Cancer","Fungal Infection, Haematological Malignancy, Blood Cancer",0.0],["A Phase 1\u002f2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia","Glanzmann Thrombasthenia",0.0],["ZN-c3 + Gemcitabine in Pancreatic Cancer","Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma",0.0],["Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)","Post COVID-19 Condition, Long COVID Syndrome, Persistent COVID-19",0.0],["TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer","Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma",0.0],["Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge","Non-Small Cell Lung Cancer",0.0],["Detoxification of the Liver In PSC (Dolphin)","Primary Sclerosing Cholangitis",0.0],["Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial","Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm",0.0],["Scalp Cooling in MBC","Metastatic Breast Cancer, Chemotherapy-induced Alopecia",0.0],["All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma","Glioma, IDH Mutation, Astrocytoma",0.0],["Tocilizumab and Tofacitinib in the Treatment of Vascular Beh\u00e7et's Syndrome","Aneurysm, Behcet Syndrome, Vascular Type",0.0],["A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old","Lupus Nephritis",0.0],["Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients","Metastatic Pancreatic Ductal Adenocarcinoma",0.0],["A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)","Myelodysplastic Syndromes",0.0],["A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract","Urothelial Carcinoma",0.0],["In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial","Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8",0.0],["RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression","Non-Muscle Invasive Bladder Cancer, HER2",0.0]],"hovertemplate":"\u003cb\u003e%{hovertext}\u003c\u002fb\u003e\u003cbr\u003e\u003cbr\u003ephase=Phase 2\u003cbr\u003eDays to Catalyst=%{x}\u003cbr\u003eMarket Cap ($)=%{y}\u003cbr\u003esize_metric=%{marker.size}\u003cbr\u003etitle=%{customdata[0]}\u003cbr\u003econdition=%{customdata[1]}\u003cbr\u003epct_change_30d=%{customdata[2]}\u003cextra\u003e\u003c\u002fextra\u003e","hovertext":[[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["NTLA",86],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["SLGN",81],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["CORT",83],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["BMY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PTCT",89],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],[null,0],["MRTX",84],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],["MRTX",84],[null,0],["VYGR",88],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["HRTX",90],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["AZN",100],[null,0],[null,0],[null,0],["CARA",80],[null,0],["REGN",100],["AZN",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PHAT",91],["CARA",89],[null,0],[null,0],[null,0],[null,0],["CARA",83],[null,0],[null,0],["REGN",100],["CRVS",90],[null,0],[null,0],[null,0],[null,0],[null,0],["INCY",100],[null,0],["BEAM",82],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],["AZN",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["AMGN",100],[null,0],[null,0],[null,0],[null,0],["BMY",100],[null,0],[null,0],[null,0],[null,0],[null,0],["NRIX",85],[null,0],[null,0],[null,0],["IMUX",91],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["SNY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],["PFE",100],[null,0],["MRNA",100],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["DNLI",100],[null,0],[null,0],["AZN",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],["PFE",100],[null,0],[null,0],[null,0],[null,0],[null,0],["DGXA",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["BMY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["BIIB",100],[null,0],[null,0],[null,0],[null,0],[null,0]],"legendgroup":"Phase 2","marker":{"color":"#636efa","size":{"dtype":"f8","bdata":"AAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8="},"sizemode":"area","sizeref":0.0025,"symbol":"circle"},"mode":"markers","name":"Phase 2","orientation":"v","showlegend":true,"x":{"dtype":"i2","bdata":"\u002f\u002f\u002f\u002f\u002f\u002f\u002f\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\u002fAIAAgACAAIAAggCCAIIAgwCEAIUAhgCGAIgAiACKAIoAigCKAIoAigCKAIoAigCKAIoAigCKAIoAigCKAIoAigCKAIsAiwCLAIsAiwCLAIsAiwCPAJAAlQCVAJcAmQCZAJkAmQCZAJkAmgCdAJ0AngCfAKEAoQCkAKQApACmAKYApwCnAKgAqACoAKgAqQCpAKkAqQCpAKkAqQCpAKkAqQCpAKkAqQCpAKkAqQCpAKkAqQCpAKoAqgCqAKoAqgCqAKoAqgCqAKoAqgCqAKoAqgCqAKoAqgCqAKoAqgCqAKoAqwCrAK8AsQA="},"xaxis":"x","y":{"dtype":"f8","bdata":"AAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8="},"yaxis":"y","type":"scatter"},{"customdata":[["A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight","Obesity, Diabetes Mellitus, Type 2",0.0],["Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure","Dexmedetomidine",0.0],["A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India","Rotavirus Infection of Children",0.0],["A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough","Cough, Refractory Chronic Cough",0.0],["Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis","Pancreatic Diseases",0.0],["Nebulized Tranexamic Acid in Sinus Surgery","Bleeding Nose",0.0],["B\u002fF\u002fTAF to DTG\u002f3TC Switch Study","HIV-1-infection",0.0],["Randomized Clinical Trial: Oral Health Package Law and Fluor Varnish Impact on Schoolchildren in Merida, Mexico","Caries, Gum Disease",0.0],["A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients","Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)",0.0],["Colchicine and Inflammation in Aortic Stenosis","Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Calcification",0.0],["Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors","Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm",0.0],["Small Bites Vs Large Bites Abdominal Midline Incisional Closure","Suture Techniques, Wound Closure Techniques, Laparotomy\u002fStanderds",0.0],["The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years","Diffuse Large B-Cell Lymphoma",0.0],["TIzanidine for the Preventive Treatment of Episodic MigrainE \uff08TIME\uff09","Migraine Without Aura, Migraine With Aura",0.0],["Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity","Stroke",0.0],["Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer","Non Small Cell Lung Cancer, Small Cell Lung Cancer",0.0],["Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","Endometrial Cancer, Atypical Endometrial Hyperplasia",0.0],["Maximal Tumor Eradication for Oligometastatic Prostate Cancer","Oligometastatic Prostate Cancer",0.0],["A Study of Apabetalone in Subjects With Long -COVID","Post-Acute COVID-19 Syndrome",0.0],["Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia","Iron Deficiency Anemia of Pregnancy",0.0],["Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer","Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8, Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8",0.0],["A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer","Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus",0.0],["Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer","Colorectal Cancer",0.0],["Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC","Non-small Cell Lung Cancer",0.0],["Teen Driving Translation Study (NIH)","Drive, Recidivism, Communication",0.0],["A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma","Small Bowel Adenocarcinoma",0.0],["Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia","Chronic Primary Immune Thrombocytopenia (ITP)",0.0],["Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)","Ischemic Stroke, Acute",0.0],["EUS-GBD vs Antibiotics for Patients at High Risk for Cholecystectomy","Acute Cholecystitis",0.0],["Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V","CKD Stage 5",0.0],["Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis","Cirrhosis",0.0],["Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC","Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)",0.0],["68Ga-DOTA-TATE PET\u002fCT Imaging in NETs","Neuroendocrine Tumors",0.0],["A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)","Relapsed or Refractory Multiple Myeloma",0.0],["Azithromycin for Critical Asthma - Pediatrics","Pediatric Asthma, Critical Illness",0.0],["Oxybutynin for Post-surgical Bladder Pain and Urgency","Overactive Bladder Syndrome, Neuropathic Bladder",0.0],["Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years","Irritable Bowel Syndrome With Constipation (IBS-C)",0.0],["Perioperative Intravenous Lidocaine in Liver Surgery","Liver Metastases, Liver Cancer, Postoperative Pain",0.0],["V114 and Acute Otitis Media (V114-032\u002fPNEU-ERA)","Acute Otitis Media (AOM)",0.0],["JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo","Monkeypox Virus Infection",0.0],["Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT","Limited Stage Small Cell Lung Cancer",0.0],["CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts","Pancreatic Cyst, EUS-FNA",0.0],["68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI","Prostate Cancer (Adenocarcinoma)",0.0],["A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer","Carcinoma, Small Cell Lung",0.0],["High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia","Anemia",0.0],["A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy","Non-small Cell Lung Cancer (NSCLC)",0.0],["Phase III Study of Toripalimab\uff08JS001\uff09 Combined With Lenvatinib for Advanced HCC","Advanced Hepatocellular Carcinoma (HCC)",0.0],["Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)","T-cell Lymphoblastic Lymphoma",0.0],["Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression","Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative",0.0],["Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ","Breast Ductal Carcinoma in Situ",0.0],["An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old","Cervical Cancer, Condylomata Acuminata",0.0],["A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy","PNH",0.0],["Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis","Cardiac Amyloidosis",0.0],["Rapid Maxillary Expansion with Low Level Laser Therapy","Crossbite, Malocclusion, Cross Bite",0.0],["Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion","Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion",0.0],["A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR\u002fMSI Status","Toripalimab, Radiation",0.0],["The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients","Methanol Poisoning",0.0],["IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia","Focal Hand Dystonia",0.0],["Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care","Depression, Cardiovascular Diseases",0.0],["Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease","Crohn Disease, Nutrient; Excess, Remission\u002fRegression",0.0],["An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.","Acute Myeloid Leukemia (AML)",0.0],["Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy","Cardiomyopathies",0.0],["Sublobar Resection for Adenocarcinoma in Situ\u002fMinimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)","Lung Adenocarcinoma, Frozen Section, Sublobar Resection",0.0],["Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma","Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma",0.0],["Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer","Gastric Cancer Stage II, Gastric Cancer Stage III, Gastric Cancer",0.0],["Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)","Immunoglobulin A Nephropathy, IgAN",0.0],["Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204\u002fKEYNOTE-204)","Hodgkin Lymphoma",0.0],["A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis","Progressive Multiple Sclerosis (PMS)",0.0],["A Study of HS-20094 in Chinese Adults with Overweight or Obesity","Overweight, Obesity",0.0],["A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection","Hepatocellular Carcinoma",0.0],["Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients","Menopause, Premature, Menopause Related Conditions, Menopausal Syndrome",0.0],["Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy","Breast Cancer",0.0],["A Study of Daratumumab","Multiple Myeloma",0.0],["Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women","Infertility, Female, Anovulatory Infertility, Menopause",0.0],["Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome","Encephalopathy, Hypoxic-Ischemic, Infant, Newborn, Diseases",0.0],["A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer","Non-Small Cell Lung Cancer",0.0],["The Study of Efficacy and Safety of Dimephosphon\u00ae in Acute Ischemic Stroke","Stroke, Acute Stroke, Ischemic Stroke",0.0],["Long-term Better Than Short-term ADT With Salvage RT","Prostate Cancer",0.0],["A Multi-center, Randomized, Double-blind, Phase II\u002fIII Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)","Recurrent or Metastatic Nasopharyngeal Carcinoma",0.0],["Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery","Postoperative Urinary Retention (POUR)",0.0],["Natural Versus Programmed Frozen Embryo Transfer (NatPro)","Pregnancy Related, Pre-Eclampsia",0.0],["A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen\u00ae) in Children Aged 6 to \u003c10 Years Compared to Children Aged 2 to \u003c6 Years","Enterovirus 71 Inactivated Vaccine",0.0],["Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer","Rectal Cancer",0.0],["Assessing Tenapanor as a Treatment of CF-related Constipation.","Cystic Fibrosis, Constipation",0.0],["LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.","Acquired Blepharophimosis",0.0],["A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease","Thyroid Eye Disease",0.0],["A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)","Carcinoma, Renal Cell",0.0],["Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission","Giant Cell Arteritis",0.0],["The Role of Peripheral Afferents in Modulating Post-stroke Central Pain","Stroke",0.0],["Lignin in Treatment of Helicobacter Pylori Infection","HELICOBACTER PYLORI INFECTIONS",0.0],["Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer","Breast Cancer, Refractory Breast Carcinoma",0.0],["Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer","Rectal Cancer",0.0],["A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin","Type 2 Diabetes",0.0],["Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","Branch Atheromatous Disease",0.0],["Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD","Cardiovascular Disease and Lipoprotein(a)",0.0],["Phase 3 Study of ALXN1850 in Treatment-Na\u00efve Pediatric Participants With HPP","Hypophosphatasia",0.0],["A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity","Neurogenic Detrusor Overactivity",0.0],["Weight Management Plus LNG-IUS\u002fMegestrol Acetate in Endometrial Atypical Hyperplasia","Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity",0.0],["To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC","Extensive Stage Small Cell Lung Cancer",0.0],["MANDARIN (S6371)","Inoperable Hepatocellular Carcinoma",0.0],["Effect of Probiotics \"Psychobiotics\" on Depression and Metabolic Syndrome in Saudi Arabia","Depression Anxiety Disorder",0.0],["Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer","Non-Small Cell Lung Cancer",0.0],["Regorafenib-pembrolizumab vs. TACE\u002fTARE in Intermediate Stage HCC Beyond Up-to-7","Carcinoma, Hepatocellular",0.0],["Study About Group and Phone Follow-Up After a Crisis","Suicide, Crisis; Emotional",0.0],["Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma","Gastric or Esophagogastric Junction Adenocarcinoma",0.0],["Clinical and Radiographic Evaluation of Three Biomimetic Materials in Pulp Therapy of Immature Young Permanent Teeth \"A Randomized Controlled Clinical Trial\"","Pulpotomy of Young Permanent Molars",0.0],["Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache","Posttraumatic Headache",0.0],["Effect of GH on the Blastocyst Euploid Rate in AMA Patients","Preimplantation Genetic Testing, Growth Hormone, Age, Parental",0.0],["Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation","Tobacco Dependence",0.0],["A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia","Warm Autoimmune Hemolytic Anemia (wAIHA)",0.0],["Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy","Modified Radical Mastectomy, Breast Cancer",0.0],["A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)","Carcinoma, Squamous Cell, Skin Neoplasms",0.0],["Aggressive Smoking Cessation Trial (ASAP)","Acute Coronary Syndrome, Cardiovascular Diseases",0.0],["Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment","Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm",0.0],["A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).","Primary Immune Thrombocytopenia",0.0],["A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy","Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC V8",0.0],["An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM","Obstructive Hypertrophic Cardiomyopathy",0.0],["A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer","Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)",0.0],["Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC","Triple Negative Breast Neoplasms",0.0],["Combination of Hypothermia and Thrombectomy in Acute Stroke","Ischemic Stroke, Large Vessel Occlusion, Endovascular Treatment",0.0],["A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin","Diabetes",0.0],["A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)","SCN2A Encephalopathy, SCN8A Encephalopathy",0.0],["Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery","Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer",0.0],["An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)","Hidradenitis Suppurativa",0.0],["Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging","Histiocytosis",0.0],["A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines","Chronic Inducible Urticaria",0.0],["GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients","Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance",0.0],["A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus","Type 2 Diabetes Mellitus",0.0],["Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty","Pain",0.0],["Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis","Moderate to Severe Atopic Dermatitis",0.0],["Veterans Affairs Seamless Phase II\u002fIII Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer","Prostate Cancer, Oligometastasis, Oligorecurrence",0.0],["Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD","Neuromyelitis Optica Spectrum Disorder",0.0],["A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer","Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma",0.0],["AMX0035 and Progressive Supranuclear Palsy","Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases",0.0],["An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)","Thyroid Eye Disease",0.0],["To Compare Efficacy and Safety of CMAB007 and Xolair\u00ae in Patients With Chronic Spontaneous Urticaria","Chronic Spontaneous Urticaria",0.0],["TMS for Exposure Therapy Resistant OCD","1 Hz Real rTMS to the Pre-SMA, 1 Hz Sham rTMS to the Pre-SMA",0.0],["24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - \u003c18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up","Chronic Spontaneous Urticaria",0.0],["Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy","Limited Stage Small Cell Lung Cancer",0.0],["Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)","Burns Surgery",0.0],["A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors","Haemophilia A and B With and Without Inhibitors",0.0],["The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms","Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina",0.0],["Liposomal Bupivacaine Use in Alveolar Bone Graft Patients","Cleft Lip and Palate",0.0],["Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration","Neovascular Age-Related Macular Degeneration",0.0],["Evaluation of Long-term Safety and Efficacy of ELX\u002fTEZ\u002fIVA in Cystic Fibrosis (CF) Participants 2 Years and Older","Cystic Fibrosis",0.0],["Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer","Breast Cancer",0.0],["Metformin in Alzheimer's Dementia Prevention","Mild Cognitive Impairment",0.0],["Multi-center Trial of Ferric Derisomaltose in Children 0 to \u003c18 Years of Age With Iron Deficiency Anemia","Iron Deficiency, Anaemia in Children",0.0],["TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)","Non Small Cell Lung Cancer",0.0],["Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","Relapsing Multiple Sclerosis",0.0],["A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.","Generalized Anxiety Disorder",0.0],["Efficacy of a Self-advocacy Serious Game Intervention","Self-Management, Quality of Life",0.0],["Neighborhood Park Youth Sports Program Fee Waiver and Intensive Family Outreach","Physical Activity",0.0],["Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)","Primary Immunodeficiency Disease",0.0],["A Study of IL4R\u03b1 Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis","Allergic Rhinitis, Seasonal",0.0],["Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","Relapsing Multiple Sclerosis",0.0],["A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)","Allergic Asthma",0.0],["Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above","Tuberculosis",0.0],["Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes","Stem Cells, Type 1 Diabetes",0.0],["Ketogenic Diet for New-Onset Absence Epilepsy","Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence",0.0],["A Study to Determine the Safety and Efficacy of NT-501 With MHFM","Macular Telangiectasia Type 2",0.0],["A Study of Intra-operative Imaging in Women With Ovarian Cancer","Ovarian Cancer, Ovarian Carcinoma",0.0],["A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis","Psoriatic Arthritis",0.0],["Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers","RSV Immunisation",0.0],["A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+\u002fHER2- Early Breast Cancer","Early Breast Cancer",0.0],["Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","Hepatocellular Carcinoma",0.0],["Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma","Nasopharyngeal Carcinoma",0.0],["A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease","Thyroid Eye Disease, TED",0.0],["Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)","Sickle Cell Disease",0.0],["Faecal Microbiota Transplantation for Liver Cirrhosis","Liver Cirrhosis",0.0],["Phase 2\u002f3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease","Proteinuric Kidney Disease",0.0],["Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers","Sleep",0.0],["Inhaled Sevoflurane for ARDS Prevention","Acute Respiratory Distress Syndrome",0.0],["A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer","Pancreatic Ductal Adenocarcinoma",0.0],["Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery","Congenital Antithrombin Deficiency",0.0],["Comparison of Standard vs. Accelerated Corneal Crosslinking","Keratoconus, Ectasia Corneal",0.0],["Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC","Esophageal Squamous Cell Carcinoma",0.0],["Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)","Cardiomyopathy, Dilated",0.0],["A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both","Diabetes Mellitus, Type 2",0.0],["A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis","Plaque Psoriasis",0.0],["A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis","Generalized Myasthenia Gravis",0.0]],"hovertemplate":"\u003cb\u003e%{hovertext}\u003c\u002fb\u003e\u003cbr\u003e\u003cbr\u003ephase=Phase 3\u003cbr\u003eDays to Catalyst=%{x}\u003cbr\u003eMarket Cap ($)=%{y}\u003cbr\u003esize_metric=%{marker.size}\u003cbr\u003etitle=%{customdata[0]}\u003cbr\u003econdition=%{customdata[1]}\u003cbr\u003epct_change_30d=%{customdata[2]}\u003cextra\u003e\u003c\u002fextra\u003e","hovertext":[[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["MRK",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["CRSP",81],[null,0],["ALXN",100],["MRK",100],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["AMGN",100],["MRK",100],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],["ALXN",100],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],[null,0],["RHHBY",100],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],[null,0],["MRK",100],[null,0],["RHHBY",100],["ARGX",80],[null,0],["OLMA",81],[null,0],["AZN",100],[null,0],["OLMA",83],["PRAX",93],[null,0],[null,0],[null,0],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],["ALXN",100],[null,0],["ALNY",87],["VKTX",88],[null,0],[null,0],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["VRTX",100],[null,0],[null,0],[null,0],[null,0],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],["NVS",100],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],[null,0],["SNY",100],["NVS",100],["AZN",100],[null,0],[null,0],[null,0],[null,0],["VRTX",100],[null,0],[null,0],[null,0],[null,0],[null,0],["AZN",100],[null,0],[null,0],[null,0],[null,0]],"legendgroup":"Phase 3","marker":{"color":"#EF553B","size":{"dtype":"f8","bdata":"AAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8AAAAAAADwPwAAAAAAAPA\u002fAAAAAAAA8D8="},"sizemode":"area","sizeref":0.0025,"symbol":"circle"},"mode":"markers","name":"Phase 3","orientation":"v","showlegend":true,"x":{"dtype":"i2","bdata":"\u002f\u002f8CAAIABQAHAAcACQAJAAkACQAKAAsADAAMABEAEQARABEAEQARABEAEQARABEAEgASABIAEgASABIAEgASABIAEgASABIAEgASABIAEgASABIAEgASABIAEgASABIAEgASABIAEgASABIAEgASABIAEgASABMAEwATABMAEwATABcAHgAhAC0ALgAwADAAMAAwADEAMQAxADIAMgAyADIAMgAyADIAMgA7ADwAPAA9AEAAQABAAEMARwBLAEwATQBNAE0ATQBNAE0ATQBNAE4ATgBOAE4ATgBPAFAAUgBUAFgAWABcAFwAXABdAF8AYABkAGcAaABrAGsAawBrAGsAbABsAGwAbABtAG0AbQBtAG4AewB+AIEAggCEAIkAigCKAIoAigCKAIoAigCKAIoAigCKAIoAiwCLAIsAiwCLAI0AowClAKcApwCoAKgAqQCpAKkAqQCpAKoAqgCqAKsAqwCrAK4AsQA="},"xaxis":"x","y":{"dtype":"f8","bdata":"AAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8AAAAAAAD4fwAAAAAAAPh\u002fAAAAAAAA+H8="},"yaxis":"y","type":"scatter"}],                        {"template":{"data":{"histogram2dcontour":[{"type":"histogram2dcontour","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"choropleth":[{"type":"choropleth","colorbar":{"outlinewidth":0,"ticks":""}}],"histogram2d":[{"type":"histogram2d","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"heatmap":[{"type":"heatmap","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"contourcarpet":[{"type":"contourcarpet","colorbar":{"outlinewidth":0,"ticks":""}}],"contour":[{"type":"contour","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"surface":[{"type":"surface","colorbar":{"outlinewidth":0,"ticks":""},"colorscale":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]]}],"mesh3d":[{"type":"mesh3d","colorbar":{"outlinewidth":0,"ticks":""}}],"scatter":[{"fillpattern":{"fillmode":"overlay","size":10,"solidity":0.2},"type":"scatter"}],"parcoords":[{"type":"parcoords","line":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatterpolargl":[{"type":"scatterpolargl","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"bar":[{"error_x":{"color":"#2a3f5f"},"error_y":{"color":"#2a3f5f"},"marker":{"line":{"color":"#E5ECF6","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"bar"}],"scattergeo":[{"type":"scattergeo","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatterpolar":[{"type":"scatterpolar","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"histogram":[{"marker":{"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"histogram"}],"scattergl":[{"type":"scattergl","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatter3d":[{"type":"scatter3d","line":{"colorbar":{"outlinewidth":0,"ticks":""}},"marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scattermap":[{"type":"scattermap","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scattermapbox":[{"type":"scattermapbox","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scatterternary":[{"type":"scatterternary","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"scattercarpet":[{"type":"scattercarpet","marker":{"colorbar":{"outlinewidth":0,"ticks":""}}}],"carpet":[{"aaxis":{"endlinecolor":"#2a3f5f","gridcolor":"white","linecolor":"white","minorgridcolor":"white","startlinecolor":"#2a3f5f"},"baxis":{"endlinecolor":"#2a3f5f","gridcolor":"white","linecolor":"white","minorgridcolor":"white","startlinecolor":"#2a3f5f"},"type":"carpet"}],"table":[{"cells":{"fill":{"color":"#EBF0F8"},"line":{"color":"white"}},"header":{"fill":{"color":"#C8D4E3"},"line":{"color":"white"}},"type":"table"}],"barpolar":[{"marker":{"line":{"color":"#E5ECF6","width":0.5},"pattern":{"fillmode":"overlay","size":10,"solidity":0.2}},"type":"barpolar"}],"pie":[{"automargin":true,"type":"pie"}]},"layout":{"autotypenumbers":"strict","colorway":["#636efa","#EF553B","#00cc96","#ab63fa","#FFA15A","#19d3f3","#FF6692","#B6E880","#FF97FF","#FECB52"],"font":{"color":"#2a3f5f"},"hovermode":"closest","hoverlabel":{"align":"left"},"paper_bgcolor":"white","plot_bgcolor":"#E5ECF6","polar":{"bgcolor":"#E5ECF6","angularaxis":{"gridcolor":"white","linecolor":"white","ticks":""},"radialaxis":{"gridcolor":"white","linecolor":"white","ticks":""}},"ternary":{"bgcolor":"#E5ECF6","aaxis":{"gridcolor":"white","linecolor":"white","ticks":""},"baxis":{"gridcolor":"white","linecolor":"white","ticks":""},"caxis":{"gridcolor":"white","linecolor":"white","ticks":""}},"coloraxis":{"colorbar":{"outlinewidth":0,"ticks":""}},"colorscale":{"sequential":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"sequentialminus":[[0.0,"#0d0887"],[0.1111111111111111,"#46039f"],[0.2222222222222222,"#7201a8"],[0.3333333333333333,"#9c179e"],[0.4444444444444444,"#bd3786"],[0.5555555555555556,"#d8576b"],[0.6666666666666666,"#ed7953"],[0.7777777777777778,"#fb9f3a"],[0.8888888888888888,"#fdca26"],[1.0,"#f0f921"]],"diverging":[[0,"#8e0152"],[0.1,"#c51b7d"],[0.2,"#de77ae"],[0.3,"#f1b6da"],[0.4,"#fde0ef"],[0.5,"#f7f7f7"],[0.6,"#e6f5d0"],[0.7,"#b8e186"],[0.8,"#7fbc41"],[0.9,"#4d9221"],[1,"#276419"]]},"xaxis":{"gridcolor":"white","linecolor":"white","ticks":"","title":{"standoff":15},"zerolinecolor":"white","automargin":true,"zerolinewidth":2},"yaxis":{"gridcolor":"white","linecolor":"white","ticks":"","title":{"standoff":15},"zerolinecolor":"white","automargin":true,"zerolinewidth":2},"scene":{"xaxis":{"backgroundcolor":"#E5ECF6","gridcolor":"white","linecolor":"white","showbackground":true,"ticks":"","zerolinecolor":"white","gridwidth":2},"yaxis":{"backgroundcolor":"#E5ECF6","gridcolor":"white","linecolor":"white","showbackground":true,"ticks":"","zerolinecolor":"white","gridwidth":2},"zaxis":{"backgroundcolor":"#E5ECF6","gridcolor":"white","linecolor":"white","showbackground":true,"ticks":"","zerolinecolor":"white","gridwidth":2}},"shapedefaults":{"line":{"color":"#2a3f5f"}},"annotationdefaults":{"arrowcolor":"#2a3f5f","arrowhead":0,"arrowwidth":1},"geo":{"bgcolor":"white","landcolor":"#E5ECF6","subunitcolor":"white","showland":true,"showlakes":true,"lakecolor":"white"},"title":{"x":0.05},"mapbox":{"style":"light"}}},"xaxis":{"anchor":"y","domain":[0.0,1.0],"title":{"text":"Days to Catalyst"}},"yaxis":{"anchor":"x","domain":[0.0,1.0],"title":{"text":"Market Cap ($)"}},"legend":{"title":{"text":"phase"},"tracegroupgap":0,"itemsizing":"constant"},"title":{"text":"Market Cap vs. Time to Catalyst"}},                        {"responsive": true}                    )                };            </script>        </div>
            </div>
            
            <h2>Upcoming Catalysts Table</h2>
            <table border="1" class="dataframe table">
  <thead>
    <tr style="text-align: right;">
      <th>completion_date</th>
      <th>ticker</th>
      <th>phase</th>
      <th>market_cap</th>
      <th>pct_change_30d</th>
      <th>condition</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>2025-12-12</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-12</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Obesity, Diabetes Mellitus, Type 2</td>
    </tr>
    <tr>
      <td>2025-12-12</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2025-12-12</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Type 2 Diabetes Mellitus (T2DM)</td>
    </tr>
    <tr>
      <td>2025-12-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Ovarian Cancer Prevention</td>
    </tr>
    <tr>
      <td>2025-12-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Dexmedetomidine</td>
    </tr>
    <tr>
      <td>2025-12-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Triple-Negative Breast Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Myeloid Leukemia</td>
    </tr>
    <tr>
      <td>2025-12-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Rotavirus Infection of Children</td>
    </tr>
    <tr>
      <td>2025-12-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Anal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-16</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Locally Advanced Adrenal Cortex Carcinoma, Adrenal Cortical Carcinoma, Stage III Adrenal Cortex Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-16</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm</td>
    </tr>
    <tr>
      <td>2025-12-17</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2025-12-18</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cough, Refractory Chronic Cough</td>
    </tr>
    <tr>
      <td>2025-12-18</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>B-Cell Lymphoblastic Leukemia/Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>PMMR, MSS, MSI-L</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Diseases</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Bleeding Nose</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Parkinson Disease, Anxiety</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>T2DM (Type 2 Diabetes Mellitus)</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>AML, ALL, MDS</td>
    </tr>
    <tr>
      <td>2025-12-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Crohn Disease, Colitis, Ulcerative</td>
    </tr>
    <tr>
      <td>2025-12-22</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>HIV-1-infection</td>
    </tr>
    <tr>
      <td>2025-12-22</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Caries, Gum Disease</td>
    </tr>
    <tr>
      <td>2025-12-22</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)</td>
    </tr>
    <tr>
      <td>2025-12-22</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double Hit Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-22</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Calcification</td>
    </tr>
    <tr>
      <td>2025-12-23</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm</td>
    </tr>
    <tr>
      <td>2025-12-23</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma</td>
    </tr>
    <tr>
      <td>2025-12-24</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Tumor, Metastases to Soft Tissue</td>
    </tr>
    <tr>
      <td>2025-12-24</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Suture Techniques, Wound Closure Techniques, Laparotomy/Standerds</td>
    </tr>
    <tr>
      <td>2025-12-25</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Diffuse Large B-Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-25</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Intracerebral Hemorrhage</td>
    </tr>
    <tr>
      <td>2025-12-25</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt-Like Lymphoma With 11q Aberration</td>
    </tr>
    <tr>
      <td>2025-12-25</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Migraine Without Aura, Migraine With Aura</td>
    </tr>
    <tr>
      <td>2025-12-25</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Lung Cancer, Small-cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2025-12-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Post Burn Facial Hyperpigmentation</td>
    </tr>
    <tr>
      <td>2025-12-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Neuroblastoma</td>
    </tr>
    <tr>
      <td>2025-12-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2025-12-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease</td>
    </tr>
    <tr>
      <td>2025-12-29</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Tinnitus</td>
    </tr>
    <tr>
      <td>2025-12-29</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer, HER2-positive</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Atopic Dermatitis</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Tumor Immunity, Immunosuppression, Radiofrequency Ablation</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Primary Immune Thrombocytopenia</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Biliary Tract Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Idiopathic Parkinson Disease</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Intrahepatic Cholangiocarcinoma</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Stroke</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Wet Age Related Macular Degeneration, Wet AMD</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Vulvar Cancer, Vulvar Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Non Small Cell Lung Cancer, Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Asthma, Obesity</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Myeloma, Newly Diagnosed, High Risk</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Endometrial Cancer, Atypical Endometrial Hyperplasia</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>End Stage Renal Disease on Dialysis, Hemodialysis, Peritoneal Dialysis</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Soft Tissue Sarcoma</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Oligometastatic Prostate Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Post-Acute COVID-19 Syndrome</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(NTLA, 86)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cutaneous Breast Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Iron Deficiency Anemia of Pregnancy</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8, Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Biliary Tract Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Kidney Cancer, Renal Cell Carcinoma, Renal Clear Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pulmonary Fibrosis</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pneumonitis</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Depression</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Neoadjuvant Immunotherapy, Cervical Cancer, Fertility-sparing Surgery</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>HCC</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Heart Failure</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(SLGN, 81)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Relapsed or Refractory Acute Myeloid Leukemia (AML)</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Tumor, Adult</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hematologic Malignancies</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Non-small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Prostate Cancer</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alzheimer Disease</td>
    </tr>
    <tr>
      <td>2025-12-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(CORT, 83)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>PD-L1-selected Solid Tumors</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Drive, Recidivism, Communication</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Neoplasm Female, Metastatic Breast Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Graft-versus-host Disease (GVHD)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Lung Injury, Prevention</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hodgkin Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cancer Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Breast Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Small Bowel Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Tuberous Sclerosis Complex, Epilepsy</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Borderline Personality Disorder</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Primary Immune Thrombocytopenia (ITP)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Cancer, Anorexia, Weight Loss</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Renal Cell Carcinoma (RCC)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Bladder Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Esophageal Cancer, Nimotuzumab, Chemoradiotherapy</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Stroke, Stroke, Ischemic, Stroke; Sequelae</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(BMY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Extensive-stage Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Ischemic Stroke, Acute</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hepatocellular Carcinoma Non-resectable, HCC</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Glioblastoma, Anaplastic Astrocytoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Cholecystitis</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>T-Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer Female</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>CKD Stage 5</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Primary Central Nervous System Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Stable Coronary Artery Disease CAD</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Crohn Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cancer Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cirrhosis</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Post Traumatic Stress Disorder, Opioid-use Disorder</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Persistent Disease, Refractory Acute Myeloid Leukemia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sickle Cell Disease, Diffuse Myocardial Fibrosis</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Neuroendocrine Tumors</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Esophageal Cancer, Nimotuzumab, Chemoradiotherapy</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Parkinson Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Relapsed or Refractory Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Esophageal Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Solid Tumors</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Malignant Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Organ Malignancies</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Minocycline, Uveitis, Retinal Degeneration</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Tumor</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Pediatric Asthma, Critical Illness</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Graft-versus-Host Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Urothelial Carcinoma, Bladder Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alcohol Use Disorder, Hiv, Tobacco Use Disorder</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Solid Tumor</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Overactive Bladder Syndrome, Neuropathic Bladder</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Irritable Bowel Syndrome With Constipation (IBS-C)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Liver Metastases, Liver Cancer, Postoperative Pain</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(MRK, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Otitis Media (AOM)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Monkeypox Virus Infection</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Head and Neck Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cigarette Smoking-Related Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Nasopharyngeal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Immune Thrombocytopenia, Treatment</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Esophageal Malignant Neoplasm Primary</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(PTCT, 89)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Locally Advanced or Metastatic Solid Tumors</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Nasopharyngeal Carcinoma (NPC)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Kidney Disease(CKD)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Head and Neck Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Intra-abdominal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Nasopharyngeal Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Castration Resistant Prostate Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non Small Cell Lung Cancer, Perioperative Complication</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Limited Stage Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Postoperative Pain, Nausea and Vomiting, Postoperative, Dizziness</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Platinum-resistant Ovarian Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Cyst, EUS-FNA</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Nasopharyngeal Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Prostate Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Mpox (Monkeypox)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alcohol Use Disorder</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Prostate Cancer (Adenocarcinoma)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Neoplasms</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Congenital Hyperinsulinism</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Ovarian Neoplasms, Ovarian Diseases</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>ER+ Breast Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Covid-19, Sars-CoV2, Pneumonia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Carcinoma, Small Cell Lung</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Malignant Neoplasm, ATM Gene Mutation, BRCA1 Gene Mutation</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Kidney Diseases, Metabolic Acidosis, Fatigue</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Malignant Fungating Wound</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>PTSD</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(PFE, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Unresectable/Metastatic Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Tumor</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Unresectable Gallbladder Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Anemia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Gland, Salivary Gland Cancers</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(MRTX, 84)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Dry Eye</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer, Heart Failure</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alzheimer Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>DLBCL</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Neovascular Age-related Macular Degeneration</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pemphigus</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>MCRC</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Healthy Adults</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Non-small Cell Lung Cancer (NSCLC)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>PCNSL</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Hepatocellular Carcinoma (HCC)</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Erythroplakia, Oral Leukoplakia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Gastric/Gastroesophageal Junction Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Malignant Female Reproductive System Neoplasm</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Erectile Dysfunction</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Promyelocytic Leukemia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>T-cell Lymphoblastic Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Asthma, Wheezing</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Primary Myelofibrosis, Secondary Myelofibrosis</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Assisted Reproduction</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chordoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Mesenchymal Chondrosarcoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Classical Hodgkin Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Aging, Insulin Resistance</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Atrial Fibrillation, Atrial Flutter</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Ocular Graft-versus-host Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Leukopenia, Neutropenia, Infections</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cavernous Malformations, Intracerebral Hemorrhage, Brainstem Stroke</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Atrial Fibrillation</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Esophagus Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Myeloid Leukemia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer With EGFR Mutation</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer, Cholangiocarcinoma, Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Ductal Carcinoma in Situ</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Anemia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cervical Cancer, Condylomata Acuminata</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>PNH</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cardiac Amyloidosis</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(MRTX, 84)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Dry Eye Disease</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Autism Spectrum Disorder</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(VYGR, 88)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Urothelial Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Gram Negative Pneumonia, Gram-Negative Bacterial Infections, Bacteremia Caused by Gram-Negative Bacteria</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Crossbite, Malocclusion, Cross Bite</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alzheimer Disease, Mild Cognitive Impairment</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>ALL, Adult, Philadelphia-Negative ALL</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Long COVID, Long COVID-19, Hypersomnia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Long COVID, Post-COVID19 Condition, Post-Acute COVID19 Syndrome</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>ST Segment Elevation Myocardial Infarction, Heart Failure</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hearing Loss, Sensorineural</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pneumonia, Critically Ill</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Toripalimab, Radiation</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Methanol Poisoning</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Glioblastoma, Recurrent, Lower Grade Glioma, Recurrent</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Focal Hand Dystonia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>NSCLC, Neoadjuvant Therapy</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Progression</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma, RAS Mutation</td>
    </tr>
    <tr>
      <td>2025-12-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Depression, Cardiovascular Diseases</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Atopic Dermatitis, Eczema</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Gastric Cancer</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(HRTX, 90)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cancer, Melanoma, Ovary Cancer</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Crohn Disease, Nutrient; Excess, Remission/Regression</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Inflammatory Disease, Aging Problems, Obese</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Myeloid Leukemia (AML)</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cardiomyopathies</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Lung Adenocarcinoma, Frozen Section, Sublobar Resection</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Esophagogastric Junction Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Stroke Rehabilitation, Gait Disorders, Neurologic, tDCS</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Ischemic Heart Disease</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Leptomeningeal Metastasis</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Sclerosis</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Pelvic Pain Syndrome</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(CRSP, 81)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Autoimmune Bullous Disease</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Gastric Cancer Stage II, Gastric Cancer Stage III, Gastric Cancer</td>
    </tr>
    <tr>
      <td>2026-01-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes</td>
    </tr>
    <tr>
      <td>2026-01-05</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Mild or Moderate Asthma With Allergic Sensitization</td>
    </tr>
    <tr>
      <td>2026-01-05</td>
      <td>(ALXN, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Immunoglobulin A Nephropathy, IgAN</td>
    </tr>
    <tr>
      <td>2026-01-06</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Grade 2 Meningioma, Grade 3 Meningioma, Recurrent Meningioma</td>
    </tr>
    <tr>
      <td>2026-01-09</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Fibrous Dysplasia</td>
    </tr>
    <tr>
      <td>2026-01-10</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Malaria, Malaria,Falciparum, Parasitic Disease</td>
    </tr>
    <tr>
      <td>2026-01-12</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Lymphocytic Leukemia, COVID-19 Infection</td>
    </tr>
    <tr>
      <td>2026-01-12</td>
      <td>(MRK, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Hodgkin Lymphoma</td>
    </tr>
    <tr>
      <td>2026-01-14</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Anterior Cruciate Ligament Reconstruction</td>
    </tr>
    <tr>
      <td>2026-01-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Malignant Neoplasm in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7</td>
    </tr>
    <tr>
      <td>2026-01-15</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Progressive Multiple Sclerosis (PMS)</td>
    </tr>
    <tr>
      <td>2026-01-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Classical Hodgkin Lymphoma</td>
    </tr>
    <tr>
      <td>2026-01-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sepsis</td>
    </tr>
    <tr>
      <td>2026-01-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma, Smoldering Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2026-01-16</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Myeloid Leukemia, Myelodysplastic Syndrome</td>
    </tr>
    <tr>
      <td>2026-01-20</td>
      <td>(AZN, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Influenza A</td>
    </tr>
    <tr>
      <td>2026-01-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer</td>
    </tr>
    <tr>
      <td>2026-01-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8</td>
    </tr>
    <tr>
      <td>2026-01-21</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, Advanced Intrahepatic Cholangiocarcinoma</td>
    </tr>
    <tr>
      <td>2026-01-27</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Overweight, Obesity</td>
    </tr>
    <tr>
      <td>2026-01-27</td>
      <td>(CARA, 80)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced or Metastatic Solid Tumors</td>
    </tr>
    <tr>
      <td>2026-01-27</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Disease or Disorder</td>
    </tr>
    <tr>
      <td>2026-01-28</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2026-01-28</td>
      <td>(REGN, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Postural Orthostatic Tachycardia Syndrome (POTS)</td>
    </tr>
    <tr>
      <td>2026-01-29</td>
      <td>(AZN, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Asthma</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Primary Biliary Cholangitis</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diffuse Large B-cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Menopause, Premature, Menopause Related Conditions, Menopausal Syndrome</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Crohns Disease</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diffuse Large B-Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hidradenitis Suppurativa</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Myelosuppression</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Infertility, Female, Anovulatory Infertility, Menopause</td>
    </tr>
    <tr>
      <td>2026-01-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma, Recurrent Central Nervous System Lymphoma</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Encephalopathy, Hypoxic-Ischemic, Infant, Newborn, Diseases</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sickle Cell Anemia, Beta Thalassemia</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multi-drug Resistant Organism</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Preterm Birth</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pharmacokinetics of Celecoxib in Children</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Alcoholic Fatty Liver Disease (NAFLD)</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Ischemia Reperfusion Injury</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Lymphomatoid Papulosis</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Spinal Disease</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Cancer, Metastatic Pancreatic Cancer</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Aplastic Anemia, TPO Receptor Agonists</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Myeloid Leukemia</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(PHAT, 91)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hypothalamic Obesity</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(CARA, 89)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Neurogenic Orthostatic Hypotension</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Triple-Negative Breast Cancer (TNBC), Brain Metastases</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Immune Thrombocytopenia (ITP), Treatment</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Stroke, Acute Stroke, Ischemic Stroke</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(CARA, 83)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non Small Cell Lung Cancer, EGFR Exon 20 Mutation</td>
    </tr>
    <tr>
      <td>2026-01-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Relapsed/Refractory Acute Myeloid Leukemia</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diffuse Large B Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Prostate Cancer</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(REGN, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(CRVS, 90)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Glioblastoma Multiforme, Adult</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Autism, Pervasive Developmental Disorder</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Malignant Neoplasms of Female Genital Organs, Ovarian Cancer, Fallopian Tube Cancer</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Rectal Cancer</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Bipolar Disorder, Bipolar Depression, Bipolar I Disorder</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Recurrent or Metastatic Nasopharyngeal Carcinoma</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(INCY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Leukemia</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Postoperative Urinary Retention (POUR)</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Pregnancy Related, Pre-Eclampsia</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Enterovirus 71 Inactivated Vaccine</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Immune-related Colitis, Colitis</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(BEAM, 82)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Solid Tumor</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Rectal Cancer</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Salivary Gland Cancer, HER2 Gene Mutation</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cystic Fibrosis, Constipation</td>
    </tr>
    <tr>
      <td>2026-02-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Acquired Blepharophimosis</td>
    </tr>
    <tr>
      <td>2026-02-02</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>HIV I Infection, Tuberculosis</td>
    </tr>
    <tr>
      <td>2026-02-04</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sarcoma, Radiosurgery</td>
    </tr>
    <tr>
      <td>2026-02-06</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Autism Spectrum Disorder (ASD)</td>
    </tr>
    <tr>
      <td>2026-02-09</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sickle Cell Disease, Thalassemia, Beta, Thalassemia</td>
    </tr>
    <tr>
      <td>2026-02-09</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Healthy</td>
    </tr>
    <tr>
      <td>2026-02-10</td>
      <td>(AMGN, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Thyroid Eye Disease</td>
    </tr>
    <tr>
      <td>2026-02-11</td>
      <td>(MRK, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Carcinoma, Renal Cell</td>
    </tr>
    <tr>
      <td>2026-02-11</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Giant Cell Arteritis</td>
    </tr>
    <tr>
      <td>2026-02-12</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Stroke</td>
    </tr>
    <tr>
      <td>2026-02-13</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Type 1 Diabetes, Diabetes Mellitus, Type 1</td>
    </tr>
    <tr>
      <td>2026-02-13</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Overweight or Obese</td>
    </tr>
    <tr>
      <td>2026-02-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>HELICOBACTER PYLORI INFECTIONS</td>
    </tr>
    <tr>
      <td>2026-02-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer, Refractory Breast Carcinoma</td>
    </tr>
    <tr>
      <td>2026-02-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Rectal Cancer</td>
    </tr>
    <tr>
      <td>2026-02-16</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia</td>
    </tr>
    <tr>
      <td>2026-02-17</td>
      <td>(PFE, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Shingles, Herpes Zoster Infection, Human</td>
    </tr>
    <tr>
      <td>2026-02-18</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Type 2 Diabetes</td>
    </tr>
    <tr>
      <td>2026-02-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation</td>
    </tr>
    <tr>
      <td>2026-02-22</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Branch Atheromatous Disease</td>
    </tr>
    <tr>
      <td>2026-02-24</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Solid Tumors, Metastatic Solid Tumors</td>
    </tr>
    <tr>
      <td>2026-02-24</td>
      <td>(AZN, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Heart Failure</td>
    </tr>
    <tr>
      <td>2026-02-25</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia</td>
    </tr>
    <tr>
      <td>2026-02-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Brain Metastases</td>
    </tr>
    <tr>
      <td>2026-02-26</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cardiovascular Disease and Lipoprotein(a)</td>
    </tr>
    <tr>
      <td>2026-02-27</td>
      <td>(ALXN, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Hypophosphatasia</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Relapsed/Refractory Peripheral T Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alcohol Drinking</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Idiopathic Pulmonary Fibrosis (IPF)</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Neurogenic Detrusor Overactivity</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Neuromyelitis Optica Spectrum Disorders</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Herpes Zoster (HZ)</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL), AML (Acute Myelogenous Leukemia), Myeloma Multiple</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Extensive Stage Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Psoriasis (PsO)</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Inoperable Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Depression Anxiety Disorder</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Bipolar Disorder, Depressive Episode</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Carcinoma, Hepatocellular</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Amyloidosis; Systemic</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Suicide, Crisis; Emotional</td>
    </tr>
    <tr>
      <td>2026-02-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Colon Cancer</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>MRI-guided Adaptive Radiotherapy, Non-small Cell Lung Cancer, Brain Metastasis</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>STEMI, STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction (MI)</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Malignant Neoplasm of Prostate, Locally Advanced Prostate Cancer</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(PFE, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Dupuytren's Disease</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma in Relapse, Refractory Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Gastric or Esophagogastric Junction Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Type 1 Diabetes (T1D)</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Pulpotomy of Young Permanent Molars</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Posttraumatic Headache</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Inflammatory Response After Surgery, Postoperative Recovery</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Preimplantation Genetic Testing, Growth Hormone, Age, Parental</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>CMV</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Clear Cell Renal Cell Carcinoma, Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Malignant Solid Neoplasm</td>
    </tr>
    <tr>
      <td>2026-03-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Tobacco Dependence</td>
    </tr>
    <tr>
      <td>2026-03-02</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Warm Autoimmune Hemolytic Anemia (wAIHA)</td>
    </tr>
    <tr>
      <td>2026-03-03</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Modified Radical Mastectomy, Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-03-03</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Solid Tumors</td>
    </tr>
    <tr>
      <td>2026-03-05</td>
      <td>(MRK, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Carcinoma, Squamous Cell, Skin Neoplasms</td>
    </tr>
    <tr>
      <td>2026-03-05</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Ischemic Stroke AIS</td>
    </tr>
    <tr>
      <td>2026-03-05</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Subchondral Insufficiency Fracture</td>
    </tr>
    <tr>
      <td>2026-03-07</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Coronary Syndrome, Cardiovascular Diseases</td>
    </tr>
    <tr>
      <td>2026-03-10</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced NSCLC</td>
    </tr>
    <tr>
      <td>2026-03-11</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm</td>
    </tr>
    <tr>
      <td>2026-03-11</td>
      <td>(ARGX, 80)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Primary Immune Thrombocytopenia</td>
    </tr>
    <tr>
      <td>2026-03-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Osteoarthritis, Knee</td>
    </tr>
    <tr>
      <td>2026-03-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC V8</td>
    </tr>
    <tr>
      <td>2026-03-15</td>
      <td>(OLMA, 81)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Obstructive Hypertrophic Cardiomyopathy</td>
    </tr>
    <tr>
      <td>2026-03-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)</td>
    </tr>
    <tr>
      <td>2026-03-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-03-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-03-16</td>
      <td>(AZN, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Triple Negative Breast Neoplasms</td>
    </tr>
    <tr>
      <td>2026-03-17</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Solid Tumor, Metastatic Solid Tumor</td>
    </tr>
    <tr>
      <td>2026-03-18</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Ischemic Stroke, Large Vessel Occlusion, Endovascular Treatment</td>
    </tr>
    <tr>
      <td>2026-03-19</td>
      <td>(AMGN, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sjogren's Syndrome</td>
    </tr>
    <tr>
      <td>2026-03-19</td>
      <td>(OLMA, 83)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Diabetes</td>
    </tr>
    <tr>
      <td>2026-03-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma</td>
    </tr>
    <tr>
      <td>2026-03-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-hodgkin Lymphoma,B Cell</td>
    </tr>
    <tr>
      <td>2026-03-23</td>
      <td>(PRAX, 93)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>SCN2A Encephalopathy, SCN8A Encephalopathy</td>
    </tr>
    <tr>
      <td>2026-03-25</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Anaplastic Thyroid Cancer</td>
    </tr>
    <tr>
      <td>2026-03-26</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer</td>
    </tr>
    <tr>
      <td>2026-03-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer, Breast Neoplasms, Endometrial Cancer, Endometrial Neoplasm, Ovarian Cancer, Ovarian Neoplasms</td>
    </tr>
    <tr>
      <td>2026-03-27</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Hidradenitis Suppurativa</td>
    </tr>
    <tr>
      <td>2026-03-29</td>
      <td>(BMY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Systemic Lupus Erythematosus</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Histiocytosis</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Urinary Retention</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Coronary Syndrome</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-squamous NSCLC</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Inducible Urticaria</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alzheimer Disease, Agitation,Psychomotor, Care Giving Burden</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Tumors, Advanced Cancer, Renal Cancer</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Type 2 Diabetes Mellitus</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(NRIX, 85)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Epilepsy, Generalized, Epilepsy, Absence</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Pain</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pulmonary Tuberculosis, Tuberculosis, Koch's Disease</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sepsis, Severe</td>
    </tr>
    <tr>
      <td>2026-03-30</td>
      <td>(IMUX, 91)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Muscle Atrophy</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Parkinson's Disease, Mild Cognitive Impairment</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Moderate to Severe Atopic Dermatitis</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Prostate Cancer, Oligometastasis, Oligorecurrence</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Rift Valley Fever</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cadasil</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Neurogenic Bladder, Post-operative Urinary Tract Infections</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Rectal Cancer</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Ischemic Stroke</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Aggressive NK Cell Leukemia</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Brain Arteriovenous Malformations</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(ALXN, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Neuromyelitis Optica Spectrum Disorder</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hemodialysis</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Allogeneic Stem Cell Transplantation</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Kidney Diseases</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV</td>
    </tr>
    <tr>
      <td>2026-03-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pain, Neuropathic Pain, Irritability</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cancer</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Minimal Residual Disease, Adjuvant Chemotherapy, Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>T-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(ALNY, 87)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(SNY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Juvenile Idiopathic Arthritis</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(VKTX, 88)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Thyroid Eye Disease</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Schizophrenia</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alcohol Misuse</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Spontaneous Urticaria</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Renal Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Metabolic Dysfunction-Associated Steatohepatitis</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Prostate Cancer</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hiv</td>
    </tr>
    <tr>
      <td>2026-04-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>1 Hz Real rTMS to the Pre-SMA, 1 Hz Sham rTMS to the Pre-SMA</td>
    </tr>
    <tr>
      <td>2026-04-02</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Overweight, Type 2 Diabetes, Obesity</td>
    </tr>
    <tr>
      <td>2026-04-02</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Spontaneous Urticaria</td>
    </tr>
    <tr>
      <td>2026-04-03</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Moderate to Severe Ulcerative Colitis</td>
    </tr>
    <tr>
      <td>2026-04-05</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Unresectable Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2026-04-08</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Solid Tumors</td>
    </tr>
    <tr>
      <td>2026-04-12</td>
      <td>(PFE, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2026-04-13</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Sub-arachnoid Haemorrhage</td>
    </tr>
    <tr>
      <td>2026-04-14</td>
      <td>(MRNA, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Norovirus Acute Gastroenteritis</td>
    </tr>
    <tr>
      <td>2026-04-15</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Limited Stage Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-04-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Alcohol Use Disorder</td>
    </tr>
    <tr>
      <td>2026-04-17</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Metastatic Castration Resistant Prostate Cancer</td>
    </tr>
    <tr>
      <td>2026-04-18</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Burns Surgery</td>
    </tr>
    <tr>
      <td>2026-04-19</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma</td>
    </tr>
    <tr>
      <td>2026-04-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Rectal Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2026-04-20</td>
      <td>(MRK, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Melanoma</td>
    </tr>
    <tr>
      <td>2026-04-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2026-04-20</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Craniopharyngiomas</td>
    </tr>
    <tr>
      <td>2026-04-21</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Haemophilia A and B With and Without Inhibitors</td>
    </tr>
    <tr>
      <td>2026-04-22</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hematologic Malignancies</td>
    </tr>
    <tr>
      <td>2026-04-22</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Esophageal Cancer, Dysphagia, Esophageal, Epigallocatechin Gallate</td>
    </tr>
    <tr>
      <td>2026-04-22</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Solid Malignancies</td>
    </tr>
    <tr>
      <td>2026-04-22</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina</td>
    </tr>
    <tr>
      <td>2026-04-23</td>
      <td>(RHHBY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Obesity or Overweight</td>
    </tr>
    <tr>
      <td>2026-04-24</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Rhinosinusitis (CRS)</td>
    </tr>
    <tr>
      <td>2026-04-24</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cleft Lip and Palate</td>
    </tr>
    <tr>
      <td>2026-04-25</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hematologic Diseases, Neoplasms</td>
    </tr>
    <tr>
      <td>2026-04-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma</td>
    </tr>
    <tr>
      <td>2026-04-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chemotherapy-induced Peripheral Neuropathy</td>
    </tr>
    <tr>
      <td>2026-04-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Cancer</td>
    </tr>
    <tr>
      <td>2026-04-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Carcinoma, Non-Small-Cell Lung</td>
    </tr>
    <tr>
      <td>2026-04-29</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Neovascular Age-Related Macular Degeneration</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(PFE, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Triple-negative Breast Cancer, Cadonilimab</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(VRTX, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cystic Fibrosis</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Influenza, Human, Arthralgia</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Malignant Pleural Effusions, NSCLC Stage IV</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(MRK, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Mild Cognitive Impairment</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Iron Deficiency, Anaemia in Children</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metabolic Dysfunction-associated Steatohepatitis (MASH)</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Non Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Relapsing Multiple Sclerosis</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Grade I Meningioma, Adult, Grade II Meningioma, Adult, Grade III Meningioma, Adult</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Fatigue Syndrome, Myalgic Encephalomyelitis</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Generalized Anxiety Disorder</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Self-Management, Quality of Life</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Asthma With Allergic Rhinitis</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Physical Activity</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Primary Immunodeficiency Disease</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(DNLI, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Parkinson Disease</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Allergic Rhinitis, Seasonal</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Rectal Cancer Patients</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Relapsing Multiple Sclerosis</td>
    </tr>
    <tr>
      <td>2026-04-30</td>
      <td>(AZN, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Obstructive Pulmonary Disease (COPD)</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Allergic Asthma</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer Female, Hormone Receptor Positive Tumor</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Tuberculosis</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Stem Cells, Type 1 Diabetes</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Lymphoma, Follicular Lymphoma, Lymphoma,Non-Hodgkin</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Locally Advanced Thymoma</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Bladder Cancer, Muscle-Invasive Bladder Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Macular Telangiectasia Type 2</td>
    </tr>
    <tr>
      <td>2026-05-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Newly Diagnosed Diffuse Large B-cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-05-03</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Ovarian Cancer, Ovarian Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-05</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Vitiligo, Generalized</td>
    </tr>
    <tr>
      <td>2026-05-06</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>PNH - Paroxysmal Nocturnal Hemoglobinuria</td>
    </tr>
    <tr>
      <td>2026-05-11</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms</td>
    </tr>
    <tr>
      <td>2026-05-11</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Aboriginal Health, Cultural Safety, Access to Interpreters</td>
    </tr>
    <tr>
      <td>2026-05-13</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Castrate-Resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)</td>
    </tr>
    <tr>
      <td>2026-05-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Colorectal Cancer</td>
    </tr>
    <tr>
      <td>2026-05-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Respiratory Tract Infections, Cold Symptoms, Exhaled Nitric Oxide</td>
    </tr>
    <tr>
      <td>2026-05-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Myeloid Leukemia, Adult</td>
    </tr>
    <tr>
      <td>2026-05-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diabetic Foot Ulcer, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)</td>
    </tr>
    <tr>
      <td>2026-05-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diabetic Kidney Disease (DKD)</td>
    </tr>
    <tr>
      <td>2026-05-15</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Autism Spectrum Disorder</td>
    </tr>
    <tr>
      <td>2026-05-16</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Head and Neck Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-19</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Gastric/Gastroesophageal Junction Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-05-19</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Posttraumatic Headache, Mild Traumatic Brain Injury</td>
    </tr>
    <tr>
      <td>2026-05-20</td>
      <td>(MRK, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Small Cell Lung Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-21</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Prostate Cancer Recurrent, Solid Tumor, Adult</td>
    </tr>
    <tr>
      <td>2026-05-23</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer Stage IV</td>
    </tr>
    <tr>
      <td>2026-05-23</td>
      <td>(PFE, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Pneumococcal Disease</td>
    </tr>
    <tr>
      <td>2026-05-25</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Psoriatic Arthritis</td>
    </tr>
    <tr>
      <td>2026-05-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma</td>
    </tr>
    <tr>
      <td>2026-05-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Bronchial Asthma</td>
    </tr>
    <tr>
      <td>2026-05-26</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)</td>
    </tr>
    <tr>
      <td>2026-05-27</td>
      <td>(SNY, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>RSV Immunisation</td>
    </tr>
    <tr>
      <td>2026-05-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Cancer, Remission</td>
    </tr>
    <tr>
      <td>2026-05-28</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-29</td>
      <td>(NVS, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Early Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-05-29</td>
      <td>(DGXA, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis</td>
    </tr>
    <tr>
      <td>2026-05-29</td>
      <td>(AZN, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Hepatocellular Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-29</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Major Depressive Disorder</td>
    </tr>
    <tr>
      <td>2026-05-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Follicular Lymphoma, Marginal Zone Lymphoma</td>
    </tr>
    <tr>
      <td>2026-05-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm</td>
    </tr>
    <tr>
      <td>2026-05-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Nasopharyngeal Carcinoma</td>
    </tr>
    <tr>
      <td>2026-05-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Diffuse Large B Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-05-30</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Nasopharyngeal Carcinoma by AJCC V8 Stage</td>
    </tr>
    <tr>
      <td>2026-05-30</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Thyroid Eye Disease, TED</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Type 1 Diabetes, type1diabetes, Type 1 Diabetes Mellitus</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Dyslipidemias</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Sickle Cell Disease</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Multiple Myeloma, Myeloma Multiple, Kahler Disease</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(BMY, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Myelofibrosis</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Systemic Lupus Erythematosus, Systemic Sclerosis, Dermatomyositis</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Lymphocytic Leukemia</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Mantle Cell Lymphoma</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Migraine, Migraine Disorders</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Antiphospholipid Syndrome (APS)</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Liver Cirrhosis</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Ovarian Cancer</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Seneorineural Deafness, Sudden Sensorineural Hearing Loss</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Waldenstrm's Macroglobulinemia</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Gastric Cancer, Metastatic</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Biphenotypic Leukemia</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(VRTX, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Proteinuric Kidney Disease</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Sleep</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Respiratory Distress Syndrome</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8</td>
    </tr>
    <tr>
      <td>2026-05-31</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Mantle Cell Lymphoma Refractory</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Giant Cell Tumor of Bone</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Marginal Zone Lymphoma</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Intrahepatic Cholangiocarcinoma (Icc)</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Acute Myeloid Leukemia With Gene Mutations, Myelodysplastic Syndrome, Myeloproliferative Neoplasm</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Pancreatic Ductal Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Congenital Antithrombin Deficiency</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Keratoconus, Ectasia Corneal</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Hepatocellular Carcinoma, HCC</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Fungal Infection, Haematological Malignancy, Blood Cancer</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Glanzmann Thrombasthenia</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Post COVID-19 Condition, Long COVID Syndrome, Persistent COVID-19</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Small Cell Lung Cancer</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Primary Sclerosing Cholangitis</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Breast Cancer, Chemotherapy-induced Alopecia</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Glioma, IDH Mutation, Astrocytoma</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Aneurysm, Behcet Syndrome, Vascular Type</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(BIIB, 100)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Lupus Nephritis</td>
    </tr>
    <tr>
      <td>2026-06-01</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Metastatic Pancreatic Ductal Adenocarcinoma</td>
    </tr>
    <tr>
      <td>2026-06-02</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Myelodysplastic Syndromes</td>
    </tr>
    <tr>
      <td>2026-06-02</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Urothelial Carcinoma</td>
    </tr>
    <tr>
      <td>2026-06-02</td>
      <td>(AZN, 100)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Esophageal Squamous Cell Carcinoma</td>
    </tr>
    <tr>
      <td>2026-06-02</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Cardiomyopathy, Dilated</td>
    </tr>
    <tr>
      <td>2026-06-02</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Diabetes Mellitus, Type 2</td>
    </tr>
    <tr>
      <td>2026-06-05</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Plaque Psoriasis</td>
    </tr>
    <tr>
      <td>2026-06-06</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8</td>
    </tr>
    <tr>
      <td>2026-06-08</td>
      <td>(None, 0)</td>
      <td>Phase 3</td>
      <td></td>
      <td>0.0</td>
      <td>Generalized Myasthenia Gravis</td>
    </tr>
    <tr>
      <td>2026-06-08</td>
      <td>(None, 0)</td>
      <td>Phase 2</td>
      <td></td>
      <td>0.0</td>
      <td>Non-Muscle Invasive Bladder Cancer, HER2</td>
    </tr>
  </tbody>
</table>
        </div>
    </body>
    </html>
    